<SEC-DOCUMENT>0001213900-25-082659.txt : 20250829
<SEC-HEADER>0001213900-25-082659.hdr.sgml : 20250829
<ACCEPTANCE-DATETIME>20250829170047
ACCESSION NUMBER:		0001213900-25-082659
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20250829
DATE AS OF CHANGE:		20250829

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LiveOne, Inc.
		CENTRAL INDEX KEY:			0001491419
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-EATING PLACES [5812]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				980657263
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-289950
		FILM NUMBER:		251281791

	BUSINESS ADDRESS:	
		STREET 1:		269 SOUTH BEVERLY DRIVE
		STREET 2:		SUITE 1450
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90212
		BUSINESS PHONE:		(310) 601-2505

	MAIL ADDRESS:	
		STREET 1:		269 SOUTH BEVERLY DRIVE
		STREET 2:		SUITE 1450
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90212

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LiveXLive Media, Inc.
		DATE OF NAME CHANGE:	20170808

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LOTON, CORP
		DATE OF NAME CHANGE:	20100507
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>ea0255072-s3_liveone.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange Commission
on August 29, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM S-3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIVEONE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>98-0657263</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction of<BR>
incorporation or organization)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer<BR>
Identification Number)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>269 S. Beverly Dr., Suite 1450</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Beverly Hills, CA 90212</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(310) 601-2505</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address, including zip code, and telephone number,
including area code, of registrant&rsquo;s principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Robert S. Ellin</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Chairman and Chief Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LiveOne, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>269 S. Beverly Dr., Suite 1450</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Beverly Hills, CA 90212</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(310) 601-2505</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address, including zip code, and telephone
number, including area code, of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Copies to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sasha Ablovatskiy, Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Jonathan Shechter, Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Foley Shechter Ablovatskiy LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>641 Lexington Ave., 14<SUP>th</SUP>&nbsp;Floor</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, NY 10022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Telephone: (212) 335-0466</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Approximate date of commencement of proposed sale
to the public:&nbsp;<B>From time to time after the effective date of this Registration Statement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the only securities being registered on this
form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. &nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on this
form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered
only in connection with dividend or interest reinvestment plans, check the following box.&nbsp;&#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering.&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering.&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this form is a registration statement pursuant
to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the following box.&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this form is a post-effective amendment to
a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities
pursuant to Rule 413(b) under the Securities Act, check the following box.&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company&rdquo;
and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer&nbsp;&#9744;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer&nbsp;&#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer&nbsp;&#9746;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company&nbsp;&#9746;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging Growth Company&nbsp;&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of Securities Act.&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The registrant hereby amends this registration
statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which
specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section
8(a), may determine.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red"><B>The information in
this prospectus is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities
and Exchange Commission. These securities may not be sold until the registration statement is effective. This prospectus is not an offer
to sell these securities and does not solicit an offer to buy these securities in any state or other jurisdiction where the offer or
sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Red">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="color: Red"><B>PRELIMINARY
PROSPECTUS, SUBJECT TO COMPLETION, DATED AUGUST 29, 2025&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIVEONE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>6,000,000 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrants to Purchase up to 3,000,000 Shares
of Common Stock </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus relates to
the offer and resale from time to time of (i) 3,000,000 shares (the &ldquo;Shares&rdquo;) of LiveOne, Inc.&rsquo;s, a Delaware corporation
(the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; or &ldquo;our&rdquo;), common stock, $0.001 par value per share (the &ldquo;common
stock&rdquo;), (ii) warrants to purchase up to an aggregate of 3,000,000 shares of common stock, exercisable at a price of $0.01 per share
(subject to adjustment as provided therein) (the &ldquo;Warrants&rdquo;), and (iii) up to 3,000,000 shares of common stock issuable upon
the exercise of the Warrants (the &ldquo;Warrant Shares&rdquo; and together with the Shares and the Warrants, the &ldquo;Securities&rdquo;),
by the selling stockholders identified in this prospectus (together with any of such stockholders&rsquo; transferees, pledgees, donees
or successors) (the &ldquo;Selling Stockholders&rdquo;). The Shares and the Warrants were issued to the Selling Stockholders in a private
placement pursuant to the Letter Agreements entered into by the Company with each of the Selling Stockholders on July 15, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders
may sell all or a portion of the Securities from time to time, in amounts, at prices and on terms determined at the time of sale.
The Securities may be sold by any means described in the section of this prospectus entitled &ldquo;Plan of Distribution&rdquo;
beginning on page 24. The Selling Stockholders may also sell the Shares under Rule 144 under the Securities Act of 1933, as amended,
if available, rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will not receive any proceeds
from the sale or other disposition of the Securities by the Selling Stockholders. However, we will receive proceeds from the exercise
of the Warrants if the Warrants are exercised and the holders of such Warrants pay the exercise price in cash upon such exercise and do
not utilize the cashless exercise provision of the Warrants. We will bear all other costs, fees and expenses incurred in effecting the
registration of the Securities covered by this prospectus. All selling and other expenses incurred by the Selling Stockholders will be
borne by the Selling Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are registering the offer
and sale of the Securities pursuant to certain registration rights granted to the Selling Stockholders. The registration of the Securities
does not necessarily mean that any Selling Stockholder will offer or sell any of their Securities or exercise their Warrants. The timing
and amount of any sale or exercise is within the sole discretion of the Selling Stockholders. We are not offering for sale any shares
of our common stock pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is listed
for trading on The Nasdaq Capital Market, or &ldquo;Nasdaq,&rdquo; under the symbol &ldquo;LVO.&rdquo; On August 22, 2025, the last reported
sale price of our common stock was $0.6008.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Investing in our securities
involves significant risks. We strongly recommend that you read carefully the risks we describe in this prospectus and in any accompanying
prospectus supplement, as well as the risk factors that are incorporated by reference into this prospectus from our filings made with
the U.S. Securities and Exchange Commission. See &ldquo;Risk Factors&rdquo; on page 8</B> <B>of this prospectus.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the U.S. Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy
or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is ____________, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_001">ABOUT THIS PROSPECTUS</A></FONT></TD>
    <TD STYLE="width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_002">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_003">PROSPECTUS SUMMARY</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_004">THE OFFERING</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_005">RISK FACTORS</A></FONT></TD>
    <TD STYLE="text-align: center">8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_006">USE OF PROCEEDS</A></FONT></TD>
    <TD STYLE="text-align: center">15<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_007">BACKGROUND OF THE OFFERING</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_008">SELLING STOCKHOLDERS</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_009">DESCRIPTION OF SECURITIES WE ARE OFFERING</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_010">PLAN OF DISTRIBUTION</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>24</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_011">LEGAL MATTERS</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_012">EXPERTS</A></FONT></TD>
    <TD STYLE="text-align: center">25<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_013">WHERE YOU CAN FIND MORE INFORMATION</A></FONT></TD>
    <TD STYLE="text-align: center">26<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_014">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should rely only on the
information contained in or incorporated by reference in this prospectus. We have not authorized anyone to provide you with different
or additional information. This prospectus does not constitute an offer to sell or the solicitation of an offer to buy any securities
other than the securities described in this prospectus or an offer to sell or the solicitation of an offer to buy such securities in any
circumstances in which such offer or solicitation is unlawful. You should assume that the information appearing in this prospectus is
accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of common stock.
Our business, financial condition, results of operations and prospects may have changed materially since such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="live_001"></A>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should read this prospectus
and the information and documents incorporated by reference carefully. Such documents contain important information you should consider
when making your investment decision. See &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Incorporation of Certain Information
by Reference&rdquo; in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus may be supplemented
from time to time to add, to update or change information in this prospectus. Any statement contained in this prospectus will be deemed
to be modified or superseded for purposes of this prospectus to the extent that a statement contained in a prospectus supplement modifies
or supersedes such statement. Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and
any statement so superseded will be deemed not to constitute a part of this prospectus. You may only rely on the information contained
in this prospectus or that we have referred you to. We have not authorized anyone to provide you with different information. This prospectus
does not constitute an offer to sell or a solicitation of an offer to buy any securities other than the securities offered by this prospectus.
This prospectus and any future prospectus supplement do not constitute an offer to sell or a solicitation of an offer to buy any securities
in any circumstances in which such offer or solicitation is unlawful. Neither the delivery of this prospectus or any prospectus supplement
nor any sale made hereunder shall, under any circumstances, create any implication that there has been no change in our affairs since
the date of this prospectus or such prospectus supplement or that the information contained by reference to this prospectus or any prospectus
supplement is correct as of any time after its date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus contains summaries
of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete
information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to
herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus
is a part, and you may obtain copies of those documents as described below under &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">LiveOne, Inc. and its consolidated
subsidiaries are referred to herein as &ldquo;LiveOne,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our,&rdquo;
unless we state otherwise or the context indicates otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="live_002"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus and the documents
incorporated by reference herein or therein, contain forward-looking statements within the meaning of Section 27A of the Securities Act
of 1933, as amended (the &ldquo;Securities Act&rdquo;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), that are intended to be covered by the &ldquo;safe harbor&rdquo; created by those sections. Forward-looking statements, which
are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of
forward-looking terms such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans,&rdquo;
&ldquo;anticipates,&rdquo; &ldquo;could,&rdquo; &ldquo;intends,&rdquo; &ldquo;target,&rdquo; &ldquo;projects,&rdquo; &ldquo;contemplates,&rdquo;
&ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;predicts,&rdquo; &ldquo;potential&rdquo; or &ldquo;continue&rdquo; or other comparable
terms. All statements other than statements of historical facts included in this prospectus and the documents incorporated by reference
herein or therein regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking
statements. These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that
could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry
results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these
forward-looking statements. These forward-looking statements are based on assumptions regarding our present and future business strategies
and the environment in which we expect to operate in the future. Important risks and factors that could cause those differences include,
but are not limited to:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Risks Related to Our Business and Industry</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We rely on our largest OEM customer for a substantial percentage of our revenue. The loss of our largest OEM customer or the significant reduction of business or growth of business from such customer could significantly adversely affect our business, financial condition and results of operations.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We rely on our relationship with our largest OEM customer for a substantial percentage of our potential subscribers who are now eligible to convert to become direct customers of LiveOne. Our inability to convert a significant number of these subscribers could cause a significant reduction of our business and could significantly adversely affect our business, financial condition and results of operations.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have incurred significant operating and net losses since our inception and anticipate that we will continue to incur significant losses for the foreseeable future.</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may require additional capital, including to fund our current debt obligations and to fund potential acquisitions and capital expenditures, which may not be available on terms acceptable to us or at all and which depends on many factors beyond our control.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our failure to meet the continued listing requirements of Nasdaq could result in a de-listing of our common stock and penny stock trading, and we may need to seek to effect a reverse stock split of our common stock to avoid delisting.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is substantial doubt about our ability to continue as a going concern.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our business is partially dependent on our ability to secure music streaming rights from Content Providers and to stream their live music and music-related video content on our platform, and we may not be able to secure such content on commercially reasonable terms or at all.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may be unable to fund any significant up-front and/or guaranteed payment cash requirements associated with our live music streaming rights, which could result in the inability to secure and retain such streaming rights and may limit our operating flexibility, which may adversely affect our business, operating results and financial condition.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We face intense competition from competitors, and we may not be able to increase our revenues, which could adversely impact our business, financial condition and results of operations.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advancements in AI technology may adversely affect our business model and competitive position.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B><I>Risks Related to Our Company</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year&nbsp;ended March 31, 2024, our management concluded that our disclosure controls and procedures and our internal control over financial reporting were not effective. If we are unable to establish and maintain effective disclosure controls and internal control over financial reporting, our ability to produce accurate financial statements on a timely basis or prevent fraud could be impaired, and the market price of our securities may be negatively affected.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We heavily depend on relationships with our Content Providers and other Industry Stakeholders and adverse changes in these relationships, could adversely affect our business, financial condition and results of operations.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We rely on key members of management, particularly our Chairman and Chief Executive Officer, Mr. Robert Ellin, and our Chief Financial Officer, Ryan Carhart, and the loss of their services or investor confidence in them could adversely affect our success, development and financial condition.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unfavorable outcomes in legal proceedings may adversely affect our business, financial conditions and results of operations.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our debt agreements contain restrictive and financial covenants that may limit our operating flexibility and our substantial indebtedness may limit cash flow available to invest in the ongoing needs of our business. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may not have the ability to repay the amounts then due under&nbsp;our senior Debentures and/or Capchase Loan (each as defined below) at maturity, required redemption payments and/or to the holders of our Series A Preferred Stock, which would have a material adverse effect on our business, operating results and financial condition.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we do not comply with the provisions of our senior Debentures, the holders of the Debentures may accelerate&nbsp;our&nbsp;obligations to them&nbsp;and require us to repay all outstanding amounts owed thereunder.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to satisfy the conditions to issue the Additional Debentures (as defined above).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may incur substantially more debt or take other actions that would intensify the risks related to our indebtedness.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Risks Related to Our Acquisition Strategy</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We can give no assurances as to when we will consummate any future acquisitions or whether we will consummate any of them at all.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Risks Related to Technology and Intellectual
Property</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We rely heavily on technology to stream content and manage other aspects of our operations and on our Content Management System. The failure of any of this technology to operate effectively could adversely affect our business.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Risks Related to Our PodcastOne Business</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PodcastOne generates a substantial portion of its revenues from its podcast and advertising sales. If PodcastOne fails to maintain or grow podcasting and advertising and e-commerce merchandise revenue, our financial results may be adversely affected.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PodcastOne faces and will continue to face competition for listeners and listener listening time.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PodcastOne&rsquo;s business is dependent upon the performance of the podcasts and their talent.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If PodcastOne fails to increase the number of listeners consuming its podcast content, our business, financial condition and results of operations may be adversely affected.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PodcastOne&rsquo;s podcasting revenue and operating results are highly dependent on the overall demand for advertising.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PodcastOne relies on integrations with advertising platforms, demand-side platforms (&ldquo;DSPs&rdquo;), proprietary platforms and ad servers, over which we exercise very little control. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Risks Related to Our E-commerce Merchandising
and Other E-commerce Business</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our business is affected by seasonality, which could result in fluctuations in our operating results.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are subject to data security and privacy risks that could negatively affect our results, operations or reputation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in tax treatment of companies engaged in e-commerce may adversely affect the commercial use of our sites and our financial results.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;<I>Risks Related to This Offering</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We have broad discretion over the use of the
net proceeds from the exercise of any Warrants for cash and may use them in ways with which you do not agree and in ways that may not
enhance our operating results or the price of our common stock.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You may lose all of your investment.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                                                                                                                            </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sales of a substantial number of shares of our
common stock in the public market by certain of our stockholders could cause our stock price to fall.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                      </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">There is no public market for the Warrants.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                                                                                                                                   </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our failure to meet the continued listing requirements
of Nasdaq could result in a de-listing of our common stock and penny stock trading, and we may need to seek to effect a reverse stock
split of our common stock to avoid delisting.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                              </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">There is substantial doubt about our ability
to continue&nbsp;as a going concern.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                     </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dilution from further financings.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Risks Related to the
Ownership of Our Common Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The market price of our common stock may be highly volatile.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We cannot guarantee that our stock repurchase program will be consummated, fully or all, or that it will enhance long-term shareholder value. Stock repurchases could also increase the volatility of the trading price of our stock and could diminish our cash reserves.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Chairman and Chief Executive Officer and stockholders affiliated with him own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales of a substantial number of shares of our common stock in the public market by certain of our stockholders could cause our stock price to fall.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We do not intend to pay dividends on our common stock so any returns will be limited to the value of our stock.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions in our Certificate of Incorporation (as amended, the &ldquo;Certificate of Incorporation&rdquo;) and Bylaws (as amended, the &ldquo;Bylaws&rdquo;) and provisions under Delaware law could make it more difficult for a third party to acquire us or increase the cost of acquiring us, even if doing so would benefit our stockholders, and may prevent or frustrate attempts by our stockholders to replace or remove our current management.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Risks Related to Our
Cryptocurrency Assets Treasury Strategy and Holdings</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our Crypto Assets Treasury Strategy (as
                                                                                                                                                     defined below) exposes us to various risks associated with cryptocurrencies.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                   </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The broader digital assets industry is subject
to counterparty risks, which could adversely impact the adoption rate, price, and use of cryptocurrencies.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                           </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We may use our cash and cash equivalents to purchase
cryptocurrencies, the price of which has been, and will likely continue to be, highly volatile.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Bitcoin, Ethereum, Solana and other digital assets
are novel assets, and are subject to significant legal, commercial, regulatory and technical uncertainty.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                          </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our historical financial statements do not reflect
the potential variability in earnings that we may experience in the future relating to our bitcoin holdings.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                             </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify">We
face risks relating to the custody of our bitcoin and other forms of Crypto (as defined below), including the loss or destruction of
private keys required to access our Crypto and cyberattacks or other data loss relating to our Crypto holdings.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                               </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Regulatory change reclassifying bitcoin or other
forms of cryptocurrencies as a security could lead to our classification as an &ldquo;investment company&rdquo; under the Investment Company
Act of 1940, as amended (the &ldquo;1940 Act&rdquo;), and could adversely affect the market price of bitcoin or other forms of cryptocurrencies
and the market price of our common stock.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                          </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We may be subject to regulatory developments
related to cryptocurrency assets and cryptocurrency markets, which could adversely affect our business, financial condition, and results
of operations.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                               </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our cryptocurrency assets treasury strategy exposes
us to risk of non-performance by counterparties.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                 </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Holders of our Debentures and Capchase, our lender,
may foreclose on any crypto asset pursuant to certain restrictive covenants in the applicable debt agreements.</FONT></TD></TR>
                                                                                                                                          </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may not actually achieve
the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking
statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking
statements we make. We have included important factors in the cautionary statements included in this prospectus, particularly in the &ldquo;Risk
Factors&rdquo; section, as well as the risk factors incorporated by reference in this prospectus, discussed under &ldquo;Item 1A-Risk
Factors&rdquo; in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025, and under similar headings in our subsequently
filed Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K, that could cause actual results or events to differ materially from
the forward-looking statements that we make. Therefore, you should not rely on the occurrence of events described in any of these forward-looking
statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint
ventures or investments we may make.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should read this prospectus
and the documents that we have filed as exhibits to this prospectus completely and with the understanding that our actual future results
may be materially different from what we expect. We undertake no obligation to publicly update any forward-looking statement, whether
as a result of new information, future developments or otherwise. New factors emerge from time to time, and it is not possible for us
to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any
factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
We qualify all of the information presented in this prospectus, any accompanying prospectus supplement and any document incorporated herein
by reference, and particularly our forward-looking statements, by these cautionary statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus includes statistical
and other industry and market data that we obtained from industry publications and research, surveys and studies conducted by third parties.
Industry publications and third-party research, surveys and studies generally indicate that their information has been obtained from sources
believed to be reliable, although they do not guarantee the accuracy or completeness of such information.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<DIV STYLE="padding-right: 2.5pt; padding-left: 2.5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="live_003"></A><B>PROSPECTUS SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>This summary highlights
certain information about us, this offering and information appearing elsewhere in this prospectus and in the documents we incorporate
by reference. This summary is not complete and does not contain all of the information that you should consider before investing in our
securities. To fully understand this offering and its consequences to you, you should read this entire prospectus carefully, including
the information referred to under the heading &ldquo;Risk Factors&rdquo; in this prospectus beginning on page 8, the financial statements
and other information incorporated by reference in this prospectus when making an investment decision. This is only a summary and may
not contain all the information that is important to you. You should carefully read this prospectus, including the information incorporated
by reference therein, and any other offering materials, together with the additional information described under the heading &ldquo;Where
You Can Find More Information.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">LiveOne, Inc. (the &ldquo;Company,&rdquo;
&ldquo;LiveOne&rdquo;, &ldquo;we,&rdquo; &ldquo;us,&rdquo; or &ldquo;our&rdquo;) is an award-winning, creator-first, music, entertainment
and technology platform focused on delivering premium experiences and content worldwide through memberships and live and virtual events.
We are a pioneer in the acquisition, distribution and monetization of live music events, Internet radio, podcasting/vodcasting and music-related
membership, streaming and video content. Through our comprehensive service offerings and innovative content platform, we provide music
fans the ability to listen, watch, attend, engage and transact. Serving a global audience, our mission is to bring the experience of live
music and entertainment to consumers wherever music and entertainment is watched, listened to, discussed, deliberated or performed around
the world. Our operating model is focused on a flywheel concept of integrated services centered on servicing and monetizing superfans
through multiple revenue streams and product/service offerings. As of June 30, 2025, we operated four core integrated services: (1) one
of the industry&rsquo;s leading online live music streaming platforms (LiveOne), (2) a fully integrated membership and advertising streaming
music service Slacker operating as LiveOne powered by Slacker, (3) a leading podcasting platform operating as PodcastOne, our majority
owned subsidiary (&ldquo;PodcastOne&rdquo;), and (4) a retailer and wholesaler of personalized merchandise and gifts operating as Custom
Personalization Solutions, Inc. (&ldquo;CPS&rdquo;). We enhance the experience by granting audiences access to premium original content,
artist exclusives and industry interviews. Our LiveOne application offers users access to live events, audio streams with access to millions
of songs and hundreds of expert-curated radio platforms and stations, original episodic content, podcasts, vodcasts, video on demand,
real-time livestreams, and social sharing of content. Today, our business is comprised of three operating segments: PodcastOne, Slacker
and our Media Group. Our Audio Group consist of our PodcastOne and Slacker subsidiaries and our Media Group consists of our remaining
subsidiaries (hereon referred to as our &ldquo;Media Operations&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We generate revenue through
the sale of membership-based services and advertising from our music offerings, from the licensing, advertising and sponsorship of our
live music and podcast content rights and services, from our expanding pay-per-view offerings and from retail sales of merchandise and
gifts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We provide services through
a dedicated over-the-top application powered by Slacker (&ldquo;LiveOne App&rdquo;) called LiveOne. Our services are delivered through
digital streaming transmissions over the Internet and/or through satellite transmissions and may be accessed on users&rsquo; desk-top,
tablets, mobile devices (iOS, Android), Roku, Apple TV, Amazon Fire, and through over-the-top (&ldquo;OTT&rdquo;), STIRR, and XUMO with
more service platforms in discussions. Our users can also access our music platform from our websites, including www.liveone.com and www.slacker.com.
Our users may also access our podcasts on www.podcastone.com or our PodcastOne app and acquire merchandise and gifts on www.personalizedplanet.com
and www.limogesjewelry.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 2.5pt; padding-left: 2.5pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding-right: 2.5pt; padding-left: 2.5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Historically, we acquired
the rights to stream our live and recorded music and broadcasts from a combination of festival owners and promoters, such as Anschutz
Entertainment Group (&ldquo;AEG&rdquo;) and Live Nation Entertainment, Inc. (&ldquo;Live Nation&rdquo;), music labels, including Universal
Music, Warner Music and Sony Music, and through individual music publishers and rights holders. Beginning mid-March 2020, the pandemic
associated with COVID-19 temporarily shut down the production of all on-ground, live music festivals and events. As a result, we pivoted
our production to 100% streaming, and began producing, curating, and broadcasting streaming music festivals, concerts and events across
our platform. In May 2020, we launched our first pay-per-view (&ldquo;PPV&rdquo;) performances across our platform, allowing artists and
fans to access a new digital compliment to live festivals, concerts and events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The majority of our content
acquisition agreements provide us the exclusive rights to produce, license, broadcast and distribute live broadcast streams of these festivals
and events throughout the world and across any digital platform, including cable, Internet, video, audio, video-on-demand (&ldquo;VOD&rdquo;)
and virtual reality (&ldquo;VR&rdquo;). We are working to expand our VOD, PPV, content catalog and content capabilities. Since 2018, we
launched LiveZone, a traveling studio originating from live music events and festivals all over the world. LiveZone combines music news,
commentary, festival updates and artist interviews, and provide context to premiere events by showcasing exotic locales, unique venues,
and artist backstories, adding &ldquo;pre-show&rdquo; and &ldquo;post-show&rdquo; segments to livestreamed artist performances and original
festival-based content. During fiscal years ended March 31, 2023 and 2022, we launched our own franchises including &ldquo;Music Lives,&rdquo;
our multi-artist virtual festival, &ldquo;Music Lives ON,&rdquo; our series of virtual live-streaming performances, &ldquo;Self Made&rdquo;
our music competition platform, &ldquo;The Lockdown Awards&rdquo;, our award show celebrating the best in quarantine content, &ldquo;The
Snubbys&rdquo;, our award show celebrating deserving artists who should have been but were not nominated for applicable awards, &ldquo;The
Breakout Awards,&rdquo; our award show celebrating some of the year&rsquo;s most iconic music, celebrities and pop culture moments and
&ldquo;One Rising&rdquo; an emerging artist program that breaks up and coming talent across the music landscape</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In July 2020, we entered the
podcasting business with the acquisition of PodcastOne and in December 2020, we entered the merchandising business with the acquisition
of CPS. On&nbsp;February 28, 2023,&nbsp;we acquired a majority interest in Splitmind LLC and Drumify LLC.&nbsp;On&nbsp;September 8,&nbsp;2023,&nbsp;PodcastOne
completed a Qualified Event (as defined below) (its spin out from the Company to become a standalone&nbsp;publicly trading company) as
a result of its direct listing on The NASDAQ Capital Market on such date (the &ldquo;Direct Listing&rdquo;). Through the operations of
our DayOne Music Publishing, Drumify and Splitmind subsidiaries, we operate our music publishing and artist and brand development businesses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 1, 2024, we announced
an amended relationship with our largest OEM customer. Effective December 1, 2024, the OEM customer no longer subsidizes our products
to some of its customers, however, we offer all OEM customer vehicles in North America the opportunity to convert to become direct subscribers
of our LiveOne music app. The direct subscription to our LiveOne app allows such users for the first time to access their LiveOne music
and LiveOne&rsquo;s other service offerings directly across all of their devices. Our LiveOne music streaming button/icon, which allows
users to directly connect their subscription to LiveOne, is expected to remain in the OEM customer&rsquo;s music streaming services dashboard
in perpetuity. The OEM customer will continue to pay us monthly for grandfathered vehicles for the term of the OEM license agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Digital Internet Radio and Music Services</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our digital Internet radio
and music services are available to users online and through automotive and mobile original equipment manufacturers (&ldquo;OEMs&rdquo;)
on a white label basis, which allow certain OEMs to customize the radio and music services with their own logos, branding and systems.
Our users are able to listen to a variety of music, radio personalities, news, sports, comedy and the audio of live music events. Our
revenue structure for our digital Internet radio and music services varies and may be in the form of (i) a free service to the listener
supported by paid advertising, (ii) paid premium membership services, and/or (iii) a fixed fee per user. The fees generated from ad-supported
and membership services are generally subject to revenue sharing arrangements with music right holders and labels, and fees to festivals,
clubs, events, concerts, artists, promoters, venues, music labels and publishers (&ldquo;Content Providers&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Podcast Services</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our podcasts are available
to users online alongside our digital Internet radio. Our users are able to listen to a variety of podcasts, from music, radio personalities,
news, entertainment, comedy and sports. PodcastOne has built a distribution network reaching over 1 billion listeners a month across all
of its own properties, LiveOne platforms, Spotify, Apple Podcasts, iHeartRadio, Samsung and over 150 shows exclusively available in Tesla
vehicles. Similar to our digital Internet radio fee structure, we monetize podcasts through (i) paid advertising or (ii) paid premium
membership services. We own one of the largest networks of podcast content in North America, which has over 300 exclusive podcast shows
that produces over 300 episodes per week and has generated over 3.6&nbsp;billion downloads during the year ended March 31, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</DIV>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<DIV STYLE="padding-right: 2.5pt; padding-left: 2.5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PodcastOne and its roster
of top performing hosts are also able to integrate unique visual elements into the podcasts they produce and distribute them via YouTube,
with PodcastOne becoming the first podcast network to utilize Adori, a pioneering interface technology. Adori&rsquo;s unique YouTube integration
technology allows podcast hosts and networks to seamlessly import episodes from RSS feeds, enhance them with visual elements and upload
enriched assets directly to YouTube. Adori&rsquo;s patented technology embeds contextual visuals, multi-format ads, augmented reality
(&ldquo;AR&rdquo;) experiences, buy buttons, polls, and other &ldquo;call to action&rdquo; features in the audio creating a more enhanced
and richer listener experience. In creating visually enhanced podcasts, Adori&rsquo;s YouTube product provides additional monetization
avenues for PodcastOne&rsquo;s slate of original programming, increased discoverability and search engine optimization presence&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to PodcastOne&rsquo;s
core business, it also built, owns and operates a solution for the growing number of independent podcasters, LaunchpadOne. LaunchpadOne
is a self-publishing podcast platform, created to provide a low or no cost tool for independent podcasters without access to parent podcasting
networks or state of the art equipment to create shows. LaunchpadOne serves as a talent pool for us to find new podcasts and talent.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June 2023, we launched
PodcastOne TV, a free ad-supported streaming television (&ldquo;FAST&rdquo;) channel that will stream the video content from PodcastOne&rsquo;s
slate of award-winning podcasts, to be distributed through MuxIP to 60 outlets, using MuxIP&rsquo;s FASTHub for OTT platform. MuxIP will
enable PodcastOne to expand its content to viewers of niche content on Smart TVs and a wide range of devices. MuxIP is a global leader
in powering the rapidly growing TV business model centered on FAST.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 8, 2023, PodcastOne
completed its spin out from our Company to become a standalone publicly traded company (the &ldquo;Spin-Out&rdquo;) as a result of PodcastOne&rsquo;s
direct listing on The NASDAQ Capital Market on such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Merchandise</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Via the operations of CPS,
we own and operate a group of web-oriented businesses specializing in the merchandise personalization industry. CPS develops, manufactures,
and distributes personalized products for wholesale and direct-to-consumer distribution. CPS offers thousands of exclusive personalized
gift items for family, home, seasonal holidays, and special events along with personalized jewelry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><I>Ancillary Products and Services</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also provide our customers
the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Regulatory Support </I>&ndash;&nbsp;streaming of music is generally subject to copyright protection. Whenever possible, we use our best efforts to clear music copyright licenses, artist streaming preferences and music publishing rights in advance of usage.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Post-Implementation Support </I>&ndash;&nbsp;once our customer&rsquo;s content is activated on the LiveOne App, we provide technical and network support, which includes 24/7 operational assistance and monitoring of our services and performance.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Live Music Events</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We produce, edit, curate and
stream live music events through (i) broadband transmission over the Internet and/or satellite networks to our users throughout the world,
where permitted (&ldquo;Digital Live Events&rdquo;) both advertisers supported and PPV events, and (ii) physical ticket sales of on-location
music events and festivals at a variety of indoor clubs and outdoor venues and arenas (&ldquo;On-premise Live Events&rdquo;). These services
allow our users to access live music content in person and over the Internet, including the ability to chat and communicate over our platform.
LiveOne provides Digital Live Events for free to our users; however, beginning in May 2020 we launched PPV capabilities and began charging
our users to view certain Digital Live Events. We monetize these live events through third party advertising and sponsorship, including
with brands such as Volkswagen, Hyundai, Facebook, Tik Tok, Porsche, and Pepsi, and selling territorial licensing rights to Tencent in
China and Ocesa in Mexico. Our cost structure varies by music event, and may include set upfront fees/artist guarantees, the amount of
which is often dependent on specific artist. A festival&rsquo;s existing production infrastructure or lack thereof, and, in turn results
in, us having a production/financial commitment to the live stream, and in some cases, we may also share the associated revenue. The fees
generated from any advertising, sponsored content, VOD/PPV and other services are generally subject to the aforementioned revenue sharing
arrangements with certain artists, festival owners and/or music right holders, when applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<DIV STYLE="padding-right: 2.5pt; padding-left: 2.5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Recent Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Debentures Financing</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 19, 2025, we, and PodcastOne
entered into a Securities Purchase Agreement (the &ldquo;Purchase Agreement&rdquo;) with the Selling Stockholders pursuant to which (i)
we sold to the Selling Stockholders our Original Issue Discount Senior Secured Convertible Debentures, as amended on August 5, 2025 (the
&ldquo;Debentures&rdquo;) in an aggregate principal amount of $16,775,000 for an aggregate cash purchase price of $15.25 million, and
(ii) if certain conditions are satisfied as set forth in the Purchase Agreement, including at least one of the Conditions (as defined
below), we may sell, at our option to the Selling Stockholders our additional Original Issue Discount Senior Secured Convertible Debentures
in an aggregate principal amount of $11,000,000 on substantially the same terms as the Debentures, in a private placement transaction.
The Debentures are convertible into shares of our common stock, $0.001 par value per share (the &ldquo;common stock&rdquo;), at the holder&rsquo;s
option at a conversion price of $2.10 per share, subject to certain customary adjustments such as stock splits, stock dividends and stock
combinations. We may sell to the Selling Stockholders the Additional Debentures (as defined in the Purchase Agreement) if within 15 months
of the May 19, 2025 date either of the following conditions have been satisfied during such 15-month period (the &ldquo;Conditions&rdquo;):
(x) the VWAP (as defined in the Purchase Agreement) of the common stock has been equal to or greater than $4.20 per share (subject to
certain customary adjustments such as stock splits, stock dividends and stock combinations) for 30 consecutive trading days, or (y) Free
Cash Flow (as defined in the Purchase Agreement) has been equal to or greater to $3,000,000 for three consecutive fiscal quarters, and
has increased in each of the foregoing quarters from the immediately preceding fiscal quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Debentures mature on May
19, 2028 and accrue interest at 11.75% per year. Commencing with the calendar month of August 2025 (subject to the following sentence),
the holders of the Debentures will have the right, at their option, to require us to redeem an aggregate of up to $100,000 of the outstanding
principal amount of the Debentures per month. For the month of August 2025, the holders may not submit a redemption notice for such a
redemption prior to August 18, 2025. Commencing from November 18, 2025, May 18, 2026 and May 18, 2027, the holders of the Debentures will
have the right, at their option, to require us to redeem an aggregate of up to $150,000, $250,000 and $300,000, respectively, of the outstanding
principal amount of the Debentures per month. We will be required to promptly, but in any event no more than two trading days after a
holder of the Debentures delivers a redemption notice to us, pay the applicable redemption amount in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the satisfaction
of certain conditions, including applicable prior notice to the holders of the Debentures, at any time after May 19, 2026, we may elect
to prepay all, but not less than all, of the then outstanding Debentures for a prepayment amount equal to the outstanding principal balance
of then outstanding Debentures plus all accrued and unpaid interest thereon, together with a prepayment premium equal to the following
(the &ldquo;Prepayment Premium&rdquo;): (a) if the Debentures are prepaid after May 19, 2026, but on or prior to May 19, 2027, 5% of the
entire outstanding principal balance of the outstanding Debentures (or the applicable portion thereof required to be prepaid by us); and
(c) if the Debentures are prepaid on or after May 19, 2027, but prior to the maturity date of the Debentures, 4% of the entire outstanding
principal balance of then outstanding Debentures (or the applicable portion thereof required to be prepaid by us). Subject to the satisfaction
of certain conditions, we shall be required to prepay the entire outstanding principal amount of all of then outstanding Debentures in
connection with a Change of Control Transaction (as defined in the Debentures) for a prepayment amount equal to the outstanding principal
balance of then outstanding Debentures, plus all accrued and unpaid interest thereon, plus the applicable Prepayment Premium based on
when such Change of Control Transaction occurs within the period set forth above applicable to such Prepayment Premium; provided, that
(x) if a Change of Control Transaction occurs on or prior to May 19, 2026, plus 10% of the entire outstanding principal balance of then
outstanding Debentures; (y) if the Specified Carve-Out Transaction (as defined in the Debentures) is consummated, we shall be required
to prepay the Debentures, in an aggregate amount equal to the lower of the outstanding principal balance of then outstanding Debentures
and $7,500,000, in each case, plus the applicable Prepayment Premium, and (z) if a Permitted Disposition (as defined in the Debentures)
pursuant to clause (g) of the definition thereof is consummated, we shall be required to prepay the Debentures in an aggregate amount
equal to the lower of the outstanding principal balance of then outstanding Debentures and 50% of the first $1,000,000 of net proceeds
resulting from such Permitted Disposition up to $1,000,000 and 25% of such net proceeds in excess of $1,000,000, in each case, plus the
applicable Prepayment Premium.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our obligations under the
Debentures can be accelerated upon the occurrence of certain customary events of default. In the event of default and acceleration of
our obligations, we would be required to pay the applicable prepayment amount described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our obligations under the
Debentures have been guaranteed under a Subsidiary Guarantee, dated as of the Closing Date (the &ldquo;Subsidiary Guarantee&rdquo;), by
certain of our wholly owned subsidiaries, including PodcastOne, Slacker, Inc. and LiveXLive, Corp. (collectively, the &ldquo;Guarantors&rdquo;).
Our obligations under the Debentures and the Guarantors&rsquo; obligations under the Subsidiary Guarantee are secured under a Security
Agreement (the &ldquo;Security Agreement&rdquo;) entered into on May 19, 2025 among our Company, the Guarantors, certain Purchasers and
JGB Collateral, LLC (the &ldquo;Agent&rdquo;) as agent for the Purchasers (the &ldquo;Security Agreement&rdquo;), by a lien on all of
our and the Guarantors&rsquo; assets, subject to certain exceptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I></I></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<DIV STYLE="padding-right: 2.5pt; padding-left: 2.5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Series A Preferred Stock
Exchange</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please see section below captioned
&ldquo;Background of the Offering&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Equity Offering</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 15, 2025, we entered
into an underwriting agreement with Lucid Capital Markets, LLC (the &ldquo;Underwriter&rdquo;) pursuant to which we agreed to issue and
sell to the Underwriter 13,608,334 shares of our common stock at an offering price of $0.75 per share and which includes the grant to
the Underwriter of an option for the issuance and sales of up to 1,775,000 additional shares (the &ldquo;Option&rdquo;) to be sold by
us (the &ldquo;Offering&rdquo;). The aggregate gross proceeds to our Company from the Offering would be approximately $9.5 million (including
the exercise of the Option), after deducting an underwriting discount of 7% of the price to the public, but before deducting expenses
payable by us in connection with the Offering. Pursuant to the underwriting agreement, we also agreed to issue the Underwriter&rsquo;s
common stock purchase warrants to purchase up to 4% of the securities sold in the Offering at an exercise price of $0.9375. The Offering,
including the Option, closed on July 17, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Bitcoin Treasury Yield
Strategy</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have engaged Arca Investment
Management, LLC (&ldquo;Arca&rdquo;), a Delaware-registered investment adviser, to provide discretionary investment management services
for our digital asset treasury account(s) pursuant to an investment management agreement. Under this arrangement, Arca manages our account
in accordance with agreed investment guidelines, which currently involve a derivatives overlay strategy on a long bitcoin position, seeking
to generate in-kind returns through the sale of call options and other structured option strategies (the &ldquo;Bitcoin Treasury Yield
Strategy&rdquo;). Arca has full investment discretion within the investment guidelines but does not act as custodian of our assets. Our
digital assets are held by Anchorage Digital (&ldquo;Anchorage Digital&rdquo;), a qualified custodian federally regulated by the Office
of the Comptroller of the Currency (&ldquo;OCC&rdquo;), which executes transactions as instructed by Arca and provides account statements
directly to us. Chartered by the OCC, Anchorage Digital follows Federal Financial Institutions Examination Council (&ldquo;FFIEC&rdquo;)
guidelines. We pay Arca a management fee and a performance fee as set forth in our investment management agreement with Arca, and these
fees are paid directly from our account with the custodian. For more information regarding our Bitcoin Treasury Yield Strategy, please
see our Registration Statement on Form S-3, Amendment No. 1, filed with the SEC on August 26, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Cryptocurrency Assets Treasury
Strategy</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WE ARE NOT REGISTERED AS
AN INVESTMENT COMPANY UNDER THE INVESTMENT COMPANY ACT OF 1940, AS AMENDED, AND OUR STOCKHOLDERS DO NOT HAVE THE PROTECTIONS ASSOCIATED
WITH OWNERSHIP OF SHARES IN A REGISTERED INVESTMENT COMPANY NOR THE PROTECTIONS AFFORDED BY THE COMMODITIES EXCHANGE ACT.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In July 2025, we adopted our
cryptocurrency treasury reserve strategy (the &ldquo;Crypto Assets Treasury Strategy&rdquo;) and subsequently selected bitcoin as our
intended initial treasury reserve asset on an ongoing basis, subject to market conditions, applicable lender consents and our anticipated
cash needs, but we may expand our treasury reserve assets to include other cryptocurrencies such as Ethereum, Solana and/or others (collectively,
&ldquo;Crypto&rdquo;). We plan to acquire and hold Crypto using cash flows from operations that exceed working capital requirements, and
from time to time, subject to market conditions, issuing equity or debt securities or engaging in other capital raising transactions with
the objective of using the proceeds to purchase Crypto. We view our Crypto holdings as long term holdings and expect to continue to accumulate
Crypto. We have not set any specific target for the amount of Crypto we seek to hold, and we will continue to monitor market conditions
in determining whether to engage in additional Crypto purchases. As of July 2025, our board of directors has authorized our Company to
acquire up to $500,000,000 of cryptocurrencies as part of the development and implementation of our Crypto Assets Treasury Strategy and/or
Bitcoin Treasury Yield Strategy. This overall strategy also contemplates that we may periodically sell Crypto for general corporate purposes
or in connection with strategies that generate tax benefits in accordance with applicable law, enter into additional capital raising transactions,
including those that could be collateralized by our Crypto holdings, and consider pursuing strategies to create income streams or otherwise
generate funds using our Crypto holdings. For more information regarding our Cryptocurrency Assets Treasury Strategy, please see our Registration
Statement on Form S-3, Amendment No. 1, filed with the SEC on August 26, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 2, 2017, our name
changed from &ldquo;Loton, Corp&rdquo; to &ldquo;LiveXLive Media, Inc.&rdquo;, and we reincorporated from the State of Nevada to the State
of Delaware, pursuant to the reincorporation merger of Loton, Corp (&ldquo;Loton&rdquo;), a Nevada corporation, with and into LiveXLive
Media, Inc., a Delaware corporation and Loton&rsquo;s wholly owned subsidiary, effected on the same date. As a result of such reincorporation
merger, Loton ceased to exist as a separate entity, with LiveXLive Media, Inc. being the surviving entity. On October 6, 2021, our name
changed from &ldquo;LiveXLive, Media Inc.&rdquo; to &ldquo;LiveOne, Inc.&rdquo; Our principal executive offices are located at 269 S.
Beverly Drive, Suite #1450, Beverly Hills, 90212. Our main corporate website address is&nbsp;www.liveone.com.&nbsp;We make available on
or through our website our periodic reports that we file with the SEC. This information is available on our website free of charge as
soon as reasonably practicable after we electronically file the information with or furnish it to the SEC. The contents of our website
are not incorporated by reference into this document and shall not be deemed &ldquo;filed&rdquo; under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<DIV STYLE="padding-right: 2.5pt; padding-left: 2.5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Available Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our main corporate website
address is www.liveone.com. Copies of our Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K, Current Reports on Form 8-K and
our other reports and documents filed with or furnished to the SEC, and any amendments to the foregoing, will be provided without charge
to any shareholder submitting a written request to the Secretary at our principal executive offices or by calling (310) 601-2505. All
of our SEC filings are also available on our website at http://ir.liveone.com/ir-home as soon as reasonably practicable after having been
electronically filed or furnished to the SEC. All of our SEC filings are also available at the SEC&rsquo;s website at www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We provide notifications of
news or announcements regarding our financial performance, including SEC filings, investor events, and press and earnings releases on
the investor relations section of our corporate website. Investors can receive notifications of new press releases and SEC filings by
signing up for email alerts on our website. Further corporate governance information, including our board committee charters and code
of ethics, is also available on our website at http://ir.liveone.com/ir-home. The information included on our website or social media
accounts, or any of the websites of entities that we are affiliated with, is not incorporated by reference into this Annual Report or
in any other report or document we file with the SEC, and any references to our website or social media accounts are intended to be inactive
textual references only.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Background of the Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 15, 2025 (the &ldquo;Effective
Date&rdquo;), we entered into letter agreements (collectively, the &ldquo;Agreements&rdquo;) with (i) Harvest Small Cap Partners Master,
Ltd. (&ldquo;HSCPM&rdquo;), (ii) Harvest Small Cap Partners, L.P. (&ldquo;HSCP&rdquo; and together with HSCPM, the &ldquo;Harvest Funds&rdquo;
or the &ldquo;Selling Stockholders&rdquo;), and (iii) Trinad Capital Master Fund Ltd., a fund controlled by Mr. Ellin, our Chief Executive
Officer, Chairman, director and principal stockholder (&ldquo;Trinad Capital&rdquo; and collectively with the Harvest Funds, the &ldquo;Holders&rdquo;),
the holders of our Series A Perpetual Convertible Preferred Stock, par value $0.001 per share (the &ldquo;Series A Preferred Stock&rdquo;),
with a stated value of $1,000 per share. Pursuant to the Agreements (i) the Harvest Funds exchanged $4,500,000 worth of its shares of
Series A Preferred Stock into 3,000,000 shares of common stock, at a price of $1.50 per share (the &ldquo;Shares&rdquo;), and Trinad Capital
exchanged $2,250,000 worth of shares of its Series A Preferred Stock into 1,500,000 shares of common stock at the same price, and (ii)
the Selling Stockholders and Trinad Capital received 3,000,000 (the &ldquo;Warrants&rdquo;) and 1,500,000 three-year warrants respectively,
to purchase common stock exercisable at a price of $0.01 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Shares and the Warrants
were issued, and the shares of the Company&rsquo;s common stock underlying the Warrants (the &ldquo;Warrant Shares&rdquo;), to the extent
exercised, will be issued, to the Selling Stockholders as restricted securities in a private placement transaction exempt from the registration
requirements of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). The Shares, the Warrants and the Warrant Shares
are collectively referred to herein as the &ldquo;Securities&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We agreed, on or prior to
the date that is 45 days after the Effective Date, to prepare and file with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;)
a Registration Statement on Form S-3 (or such other form as applicable) covering the resale under the Securities Act of the Shares, the
Warrants and the Warrant Shares. We agreed to use our commercially reasonable best efforts to cause such registration statement to be
declared effective promptly thereafter on or before 45 days after the filing of such registration statement (or if the SEC issues any
comments with respect to such registration statement, on or before 90 days after the filing of such registration statement). Upon effectiveness
of such Registration Statement, we agreed to use our reasonable best efforts to keep the Registration Statement effective with the SEC
for a period equal to three years from the Effective Date for the Warrants, and with respect to the Shares and the Warrant Shares, so
long as any Warrants or Shares are outstanding or held by Holder, as applicable, and to supplement, amend and/or re-file such Registration
Statement to comply with such effectiveness requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accordingly, we are registering
for resale the sale and offer of the Securities to comply with such obligations to the Selling Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<DIV STYLE="padding-right: 2.5pt; padding-left: 2.5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="live_004"></A><B>THE OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are registering for resale
by the Selling Stockholders: (i) 3,000,000 shares of our common stock, (ii) Warrants to purchase up to an aggregate of 3,000,000 shares
of our common stock, and (iii) up to 3,000,000 shares of our common stock issuable upon the exercise of the Warrants (referred to in this
prospectus as the Warrant Shares) as described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Securities being offered by the Selling Stockholders:</I></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 54%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) 3,000,000 shares of our common stock; (ii) Warrants to purchase up to an aggregate of 3,000,000 shares of our common stock, exercisable at a price of $0.01 per share (subject to adjustment as provided therein); and (iii) up to 3,000,000 shares of our common stock issuable upon the exercise of the Warrants<SUP>(1)</SUP></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Common stock outstanding prior to offering:</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">115,413,332&nbsp;shares<SUP>(1)</SUP></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Common stock outstanding after the offering:</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">121,413,332 shares<SUP>(1)(2)</SUP></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Terms of the offering:</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each Selling Stockholder will determine when and how it will sell the Securities offered in this prospectus, as described in &ldquo;Plan of Distribution.&rdquo;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Use of proceeds:</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All the Securities sold
    under this prospectus will be sold or otherwise disposed of for the account of the Selling Stockholders, or their pledgees,
    assignees or successors-in-interest. We will not receive any of the proceeds from the sale or other disposition of the Securities by
    the Selling Stockholders. However, we will receive proceeds from the exercise of the Warrants if the Warrants are exercised and the
    holders of such Warrants pay the exercise price in cash upon such exercise and do not utilize the cashless exercise provision of the
    Warrants. Assuming the exercise in full of all such Warrants for cash, we will receive up to an aggregate of approximately $30,000
    from the exercise of all of the Warrants. See &ldquo;<I>Use of Proceeds</I>&rdquo; beginning on page 15 of this
    prospectus.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Market for Common Stock:</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our common stock is listed on The Nasdaq Capital Market under the symbol &ldquo;LVO.&rdquo; The Warrants are not listed on Nasdaq, any national securities exchange or any other nationally recognized trading system.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Risk Factors</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing in our
    securities involves a high degree of risk. You should carefully consider all the information included or incorporated by reference
    in this prospectus prior to investing in our common stock. In particular, we urge you to carefully read the &ldquo;Risk
    Factors&rdquo; section beginning on page 8 of this prospectus and in the documents incorporated by reference in this
    prospectus.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares of common stock outstanding after this offering is based on 115,413,332&nbsp;shares of our common stock issued and outstanding as of August 22, 2025, and excludes:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,600,000
shares of our common stock pursuant to our 2016 Equity Incentive Plan (as amended, the &ldquo;2016 Plan&rdquo;), that are reserved for
future issuance to our employees, directors and consultants, of which 2,631,830 shares of our common stock are underlying outstanding
awards under the 2016 Plan as of August 22, 2025;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately
3,755,274 shares of our common stock issuable in the event of conversion of our Series A Preferred Stock issued and outstanding (including
accrued dividends) as of August 22, 2025;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately
7,988,095 shares of our common stock issuable in the event of conversion of our Debentures issued and outstanding as of August 22, 2025;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,335,399
shares of our common stock issuable upon the exercise of our outstanding warrants as of August 22, 2025 (excluding the Warrants being
registered herein).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, all information in this prospectus assumes no exercise of any outstanding options or warrants to purchase our common
stock and no vesting of RSUs.</FONT></TD>
</TR></TABLE>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0px"></TD><TD STYLE="width: 24px; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
amount reflects up to 3,000,000 Warrant Shares issuable upon the exercise of the Warrants.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

</DIV>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="live_005"></A><B>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Investing in our securities
involves a high degree of risk. Before you make a decision to invest in our securities, you should consider carefully the risks described
below, together with other information in this prospectus and the information incorporated by reference herein, including any risk factors
contained in our Annual Report on Form 10-K, filed with the SEC on July 15, 2025, our Quarterly Report on Form 10-Q, filed with the SEC
on August 14, 2025, and in our other reports filed with the SEC and in future reports that we will file periodically or any amendments
or updates thereto. If any of the following events actually occur, our business, operating results, prospects or financial condition could
be materially and adversely affected. This could cause the trading price of our common stock to decline and you may lose part or all of
your investment. The risks described below are not the only ones that we face. Additional risks not presently known to us or that we currently
deem immaterial may also significantly impair our business operations and could result in a complete loss of your investment.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to this Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>We have broad discretion
over the use of the net proceeds from the exercise of any Warrants for cash and may use them in ways with which you do not agree and in
ways that may not enhance our operating results or the price of our common stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors and
management will have broad discretion over the application of the net proceeds that we receive from any exercise of the Warrants for cash.
We may spend or invest these proceeds in ways with which our stockholders disagree or that do not yield a favorable return, if at all.
We intend to use the net proceeds from any exercise of the Warrants for cash, together with our existing cash resources as described in
&ldquo;Use of Proceeds.&rdquo; However, our use of these proceeds may differ substantially from our current plans. Failure by our management
to apply these funds effectively could harm our business, results of operations, cash flows, financial condition and/or prospects. Pending
use, we may invest the net proceeds from the offering in a manner that does not produce income or that loses value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>You may lose all of your investment.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investing in our common stock
involves a high degree of risk. As an investor, you might never recoup all, or even part of, your investment and you may never realize
any return on your investment. You must be prepared to lose all your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Sales of a substantial
number of shares of our common stock in the public market by certain of our stockholders could cause our stock price to fall.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sales of a substantial number
of shares of our common stock in the public market or the perception that these sales might occur, could depress the market price of our
common stock and could impair our ability to raise capital through the sale of additional equity securities. We are unable to predict
the effect that sales may have on the prevailing market price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>There is no public market
for the Warrants.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Warrants are not listed
on an exchange. A liquid trading market for the Warrants may never develop, or if developed, it may not be sustained. In the absence of
a liquid public trading market for the Warrants:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you may not be able to liquidate your investment in the Warrants;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">you may not be able to resell the Warrants at favorable prices, or at all;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the market price of the Warrants may experience significant price volatility; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there may be less efficiency in carrying out your purchase and sale orders.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Our failure to meet
the continued listing requirements of Nasdaq could result in a de-listing of our common stock and penny stock trading, and we may need
to seek to effect a reverse stock split of our common stock to avoid delisting.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In March 2025, we received
a notice from the Listing Qualifications Department of the Nasdaq Stock Market (&ldquo;Nasdaq&rdquo;), regarding the fact that the market
price of our common stock was below the $1.00 minimum bid price requirement for continued listing (the &ldquo;Bid Price Rule&rdquo;).
There can be no assurance that we will be able to correct the Bid Price Rule deficiency, or that we will be able to continue to meet all
of the other criteria necessary for Nasdaq to allow us to remain listed. In November 2024, we also received a notification letter from
the Listing Qualifications Department of Nasdaq confirming that we have a cure period until the earlier of (i) October 4, 2025 and (ii)
our next annual meeting of stockholders (which is currently scheduled for September 8, 2025), to fill the vacancy created by the resignation
of the former third member of our Audit Committee, which occurred on October 4, 2024, in order to comply with the audit committee requirements
set forth in Nasdaq Listing Rule 5605. To fill the vacancy created by such resignation, we anticipate that one or more existing independent
members of our board of directors will be appointed to our Audit Committee and/or the Nominating and Corporate Governance Committee. We
are also conducting a search to find a well-qualified candidate to serve on our board of directors and/or such committees that has the
applicable experience and the necessary qualifications, skills and perspective. If we fail to satisfy the applicable continued listing
requirement and continue to be in non-compliance after notice and the applicable grace period ends (which is six months in the case of
the Bid Price Rule, subject to an additional six-month extension), Nasdaq may commence delisting procedures against our Company (during
which we may have additional time of up to six months to appeal and correct our non-compliance). At that time, we may appeal the relevant
delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there
can be no assurance that, if we do appeal the delisting determination by Nasdaq to the panel, that such appeal would be successful. In
order to regain compliance with the Bid Price Rule we may need to seek to effect a reverse stock split of our common stock prior to September
24, 2025, subject to up to a 180-day extension, if granted to us by Nasdaq. We are seeking shareholder approval at our 2025 Annual Meeting
of stockholders to allow our board of directors to implement a reverse stock split at a ratio to be determined in the discretion of our
board of directors within a range of no less than one-for-three through one-for-ten (without reducing the authorized number of shares
of common stock) (the &ldquo;Reverse Split&rdquo;). There can be no assurance we will be able to obtain stockholder approval for the Reverse
Split. We may be unable to complete a Reverse Split, and even if we do, we may still be unable to meet the minimum bid price requirement,
and we may be unable to meet other applicable Nasdaq listing requirements, including maintaining minimum levels of shareholders&rsquo;
equity or market values of our common stock. We will continue to actively monitor the closing bid price of our common stock and will evaluate
available options to resolve the deficiency and regain compliance with the Bid Price Rule. There can be no assurance that we will be able
to regain compliance with the Bid Price Rule and thereby to maintain the listing of its common stock on The Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If our common stock is ultimately
delisted from Nasdaq, our common stock would likely then trade only in the over-the-counter market and the market liquidity of our common
stock could be adversely affected and their market price could decrease. If our common stock were to trade on the over-the-counter market,
selling our common stock could be more difficult because smaller quantities of shares would likely be bought and sold, transactions could
be delayed, and we could face significant material adverse consequences, including: a limited availability of market quotations for our
securities; reduced liquidity with respect to our securities; a determination that our shares are a &ldquo;penny stock,&rdquo; which will
require brokers trading in our securities to adhere to more stringent rules, possibly resulting in a reduced level of trading activity
in the secondary trading market for our securities; a reduced amount of news and analyst coverage for our Company; and a decreased ability
to issue additional securities or obtain additional financing in the future. These factors could result in lower prices and larger spreads
in the bid and ask prices for our common stock and would substantially impair our ability to raise additional funds and could result in
a loss of institutional investor interest and fewer development opportunities for us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the foregoing,
if our common stock is ultimately delisted from Nasdaq and they trade on the over-the-counter market, the application of the &ldquo;penny
stock&rdquo; rules&nbsp;could adversely affect the market price of our common stock and increase the transaction costs to sell those shares.
The SEC has adopted regulations which generally define a &ldquo;penny stock&rdquo; as an equity security that has a market price of less
than $5.00 per share, subject to specific exemptions. If our common stock is ultimately delisted from Nasdaq and then trade on the over-the-counter
market at a price of less than $5.00 per share, our common stock would be considered a penny stock. The SEC&rsquo;s penny stock rules&nbsp;require
a broker-dealer, before a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure
document that provides information about penny stocks and the risks in the penny stock market. The broker-dealer must also provide the
customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and the salesperson in the transaction,
and monthly account statements showing the market value of each penny stock held in the customer&rsquo;s account. In addition, the penny
stock rules&nbsp;generally require that before a transaction in a penny stock occurs, the broker-dealer must make a special written determination
that the penny stock is a suitable investment for the purchaser and receive the purchaser&rsquo;s agreement to the transaction. If applicable
in the future, these rules&nbsp;may restrict the ability of brokers-dealers to sell our common stock and may affect the ability of investors
to sell their shares, until our common stock no longer is considered a penny stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I></I></B></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>There is substantial
doubt about our ability to continue&nbsp;as a going concern.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our&nbsp;independent registered
public accounting firm has issued an opinion on our audited financial statements incorporated by reference in this prospectus that contains
an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern because we have experienced recurring
losses, negative cash flows from operations, and limited capital resources. These events and conditions indicate that a material uncertainty
exists that may cast significant doubt on our ability to continue as a going concern. The perception that we may not be able to continue
as a going concern may have a material adverse effect on our share price and our ability to raise new capital (whether it is through the
issuance of equity or debt securities or otherwise), enter into critical contractual relations with third parties and otherwise execute
our business objectives. Until we can generate significant profit from operations and positive cash flow from operations, we expect to
satisfy our future cash needs through debt and/or equity financing. We cannot be certain that additional funding will be available to
us on acceptable terms, if at all. Our financial statements do not include any adjustments that may result from the outcome of this uncertainty.
If we are unable to continue as a going concern, we may have to curtail some or all of our ongoing operations and/or liquidate some or
all of our assets, and the values we receive for our assets in liquidation or dissolution could be significantly lower than the values
reflected in our financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B><I>Dilution
from further financings.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Future
sales and issuances of our common stock, common stock equivalents and/or rights to purchase common stock, including pursuant to our equity
incentive plans or our at-the-market sales agreement with Roth Capital Partners, LLC, could result in additional dilution of the percentage
ownership of our stockholders and could cause our stock price to fall. Additional capital will be needed in the future to continue our
planned operations. To the extent we raise additional capital by issuing equity securities, our stockholders may experience substantial
dilution. We may sell common stock, convertible securities or other equity securities in one or more transactions at prices and in a manner
we determine from time to time. If we sell common stock, convertible securities or other equity securities in more than one transaction,
investors may be materially diluted by subsequent sales. These sales may also result in material dilution to our existing stockholders,
and new investors could gain rights superior to our existing stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to our Common Stock </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>A substantial number
of shares of our common stock may be issued pursuant to the terms of the Series A Preferred Stock and/or Debentures. Conversion of our
Series A Preferred Stock and/or Debentures will dilute the ownership interest of our existing stockholders or may otherwise depress the
price of our common stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As
of August 22, 2025, the shares of our Series A Preferred Stock are convertible into approximately 3.76&nbsp;million shares of our common
stock at a conversion price of $2.10 per share, and our outstanding Debentures are convertible into approximately 7.99 million shares
of our common stock at a conversion price of $2.10 per share. The Series A Preferred Stock and/or Debentures likely will be converted
only at times when it is economically beneficial for the holders to do so. The conversion of some or all of the shares of our Series A
Preferred Stock and/or Debentures into shares of our common stock will dilute the ownership interests of our existing stockholders. In
addition, any sales in the public market of the shares of our common stock issuable upon such conversion and/or any anticipated conversion
of the Series A Preferred Stock and/or Debentures into shares of our common stock could adversely affect prevailing market prices of our
common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B><I>Future
sales and issuances of our common stock or rights to purchase common stock, including pursuant to our equity incentive plan and any acquisition
or financing agreement, could result in additional dilution of the percentage ownership of our stockholders and could cause our stock
price to fall.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
expect that significant additional capital will be needed in the future to continue our planned operations. To the extent we raise additional
capital by issuing equity and/or convertible securities, our stockholders may experience substantial dilution. We may sell or otherwise
issue our common stock, convertible securities or other equity securities in one or more transactions at prices and in a manner we determine
from time to time. If we sell or issue our common stock, convertible securities or other equity securities in more than one transaction,
investors may be materially diluted by subsequent issuances. These issuances may also result in material dilution to our existing stockholders,
and new investors could gain rights superior to our existing stockholders. We may pay for future acquisitions with additional issuances
of shares of our common stock as well, which would result in further dilution for existing stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to our 2016 Equity Incentive Plan (as amended, the &ldquo;2016 Plan&rdquo;), there are 17,600,000 shares of our common stock reserved
for future issuance to our employees, directors and consultants. If our board of directors elects to issue additional shares of our common
stock, stock options, restricted stock units and/or other equity-based awards under the 2016 Plan, as amended, our stockholders may experience
additional dilution, which could cause our stock price to fall.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>The market price of
our common stock may be highly volatile.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The trading price of our common
stock may be volatile. Our stock price could be subject to wide fluctuations in response to a variety of factors, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual or anticipated fluctuations in our revenue and other operating results;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actions of securities analysts who initiate or maintain coverage of us, changes in financial estimates by any securities analysts who follow our company, or our failure to meet these estimates or the expectations of investors;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">issuance of our equity or debt securities, or disclosure or announcements relating thereto;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the lack of a meaningful, consistent and liquid trading market for our common stock;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additional shares of our common stock being sold into the market by us or our stockholders or the anticipation of such sales;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our convertible debt securities being converted into equity or the anticipation of such conversion;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements by us or our competitors of significant events or features, technical innovations, acquisitions, strategic partnerships, joint ventures or capital commitments;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in operating performance and stock market valuations of companies in our industry;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">price and volume fluctuations in the overall stock market, including as a result of trends in the economy as a whole;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expiration of the lock-up period, as more fully discussed below;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lawsuits threatened or filed against us;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory developments in the United States and foreign countries; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other events or factors, including those resulting from the impact of war or incidents of terrorism, other epidemics, or responses to these events.&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the stock market
in general has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance
of these companies. Broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual
operating performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>We cannot guarantee
that our stock repurchase program will be consummated fully or that it will enhance long-term shareholder value. Stock repurchases could
also increase the volatility of the trading price of our stock and could diminish our cash reserves.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have announced that our
senior management and/or board of directors has authorized the repurchase up to approximately $12 million worth of shares of our outstanding
common stock from time to time, subject to any applicable approvals and consents, which LiveOne fully expects to obtain. The timing, price,
and quantity of purchases under the program will be at the discretion of our management and will depend upon a variety of factors including
share price, general and business market conditions, compliance with applicable laws and regulations, corporate and regulatory requirements,
and alternative uses of capital. The program may be expanded, suspended, or discontinued by our board of directors at any time. Although
our board of directors has authorized this stock repurchase program, there is no guarantee as to the exact number of shares, if any, that
will be repurchased by us, and we may discontinue purchases at any time that management determines additional purchases are not warranted.
We cannot guarantee that the program will be consummated, fully or all, or that it will enhance long-term stockholder value. The program
could affect the trading price of our common stock and increase volatility, and any announcement of a termination of this program may
result in a decrease in the trading price of our common stock. In addition, this program could diminish our cash reserves.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Our Chairman and Chief
Executive Officer and stockholders affiliated with him own a significant percentage of our stock and will be able to exert significant
control over matters subject to stockholder approval.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Ellin, our Chief Executive
Officer and Chairman, and his affiliates beneficially owned approximately 19.2% of shares of our common stock issued and outstanding as
of August 22, 2025&nbsp;(not including Mr. Ellin&rsquo;s options which have an exercise price substantially above the market price of
our common stock as of the date of this Annual Report). Therefore, Mr. Ellin and stockholders affiliated with him may have the ability
to influence us through their ownership positions. Mr. Ellin and these stockholders may be able to determine or significantly influence
all matters requiring stockholder approval. For example, Mr. Ellin and these stockholders, acting together, may be able to control or
significantly influence elections of directors, amendments of our organizational documents, or approval of any merger, sale of assets,
or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock
that you may believe are in your best interest as one of our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>FINRA sales practice
requirements may limit a stockholder&rsquo;s ability to buy and sell our stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Financial Industry Regulatory
Authority (&ldquo;FINRA&rdquo;), has adopted rules requiring that, in recommending an investment to a customer, a broker-dealer must have
reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative or low-priced securities
to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer&rsquo;s financial
status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA has indicated its belief
that there is a high probability that speculative or low-priced securities will not be suitable for at least some customers. If these
FINRA requirements are applicable to us or our securities, they may make it more difficult for broker-dealers to recommend that at least
some of their customers buy our common stock, which may limit the ability of our stockholders to buy and sell our common stock and could
have an adverse effect on the market for and price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B><I>If
securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our share price
and trading volume could decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
trading market for our shares of common stock will be influenced by the research and reports that securities or industry analysts publish
about us. Securities and industry analysts currently provide publish limited research focused on our Company. If the current securities
or industry analysts do not provide extensive coverage or commence coverage of our Company, the price and trading volume of our shares
of common stock could be negatively impacted. If other securities or industry analysts initiate coverage and one or more of the analysts
who cover us downgrade our shares of common stock or publish inaccurate or unfavorable research about our Company, the price of our shares
of common stock would likely decline. Furthermore, if one or more of these analysts cease coverage of our Company or fail to publish reports
on us regularly, demand for our shares of common stock could decrease, which might cause the price of our shares of common stock and trading
volume to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B><I>As
a smaller reporting company, we are subject to scaled disclosure requirements that may make it more challenging for investors to analyze
our results of operations and financial prospects</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the market value of
our common stock held by non-affiliates was less than $250 million as of the last business day of our fiscal quarter ended September 30,
2024, we continue to be a &ldquo;smaller reporting company&rdquo; as defined by the SEC&rsquo;s revised rules. As a &ldquo;smaller reporting
company,&rdquo; we (i) are able to provide simplified executive compensation disclosures in our filings, (ii) are exempt from the provisions
of Section 404(b) of the Sarbanes-Oxley Act requiring that independent registered public accounting firms provide an attestation report
on the effectiveness of internal control over financial reporting, and (iii) have certain other decreased disclosure obligations in our
filings with the SEC, including being required to provide only two years of audited financial statements in our annual reports. Consequently,
it may be more challenging for investors to analyze our results of operations and financial prospects.&nbsp;We will remain a smaller reporting
company if we have either (i) a public float of less than $250 million held by non-affiliates as of the last business day of the second
quarter of our then current fiscal year or (ii) annual revenues of less than $100 million during such recently completed fiscal year with
less than $700 million in public float as of the last business day of the second quarter of such fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>If securities or industry
analysts publish inaccurate or unfavorable research about our business, our stock price could decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The trading market for our
common stock will depend in part on the research and reports that securities or industry analysts publish about us or our business. If
one or more of the analysts who cover us downgrade our common stock or publish inaccurate or unfavorable research about our business,
our common stock price would likely decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Our ability to use our
net operating loss carryforwards and certain other tax attributes may be limited.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 382 and 383 (&ldquo;Section
382 and 383&rdquo;) of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;), contains rules that limit the ability of
a company that undergoes an ownership change to utilize its net operating losses (&ldquo;NOLs&rdquo;) and tax credits existing as of the
date of such ownership change. Under the rules, such an ownership change is generally any change in ownership of more than 50% of a company&rsquo;s
stock within a rolling three-year period. The rules generally operate by focusing on changes in ownership among stockholders considered
by the rules as owning, directly or indirectly, 5% or more of the stock of a company and any change in ownership arising from new issuances
of stock by the company. As a result of these Section 382 and 383 limitations, any ownership changes as defined by Section 382 and 383
may limit the amount of NOL carryforwards that could be utilized annually to offset future taxable income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>We do not intend to
pay dividends on our common stock so any returns will be limited to the value of our stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have never declared or
paid any cash dividend on our common stock. We currently anticipate that we will retain future earnings for the development, operation
and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. Additionally, any
credit and security agreement that we may enter into in the future will likely contain covenants that will restrict our ability to pay
dividends. Any return to stockholders will therefore be limited to the appreciation of their stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>The restrictive covenants
contained in the Debentures could adversely affect our business plan, liquidity, financial condition, and results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Debentures contain restrictive
covenants, including maintenance of minimum free cash covenant. These covenants could have important consequences on our business. In
particular, they could:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limit our flexibility in planning for, or reacting to, changes in our businesses and the industries in which we operate;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase our vulnerability to general adverse economic and industry conditions;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">require us to dedicate a substantial portion of our cash flow from operations to maintain on deposit in one or more accounts of our bank accounts an aggregate required amount equal to the Cash Minimum (as defined in the Debentures), unless otherwise permitted by the written consent of the holders of the Debentures; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potentially place us at a competitive disadvantage compared to our competitors that have lower fixed costs.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we are required
to redeem the Debentures monthly in cash and may not do so in shares of our common stock. The debt service requirements of our other outstanding
indebtedness, as well as any other indebtedness or preferred stock we incur or issue in the future, and the restrictive covenants contained
in the governing documents for such indebtedness or preferred stock, could intensify these risks. As a result of us being required to
redeem the Debentures in cash, we may seek to refinance the remaining balance, by either refinancing with the holders of the Debentures,
by raising sufficient funds through a sale of equity or debt securities or by obtaining a credit facility. No assurances can be given
that we will be successful in making the required payments under the Debentures, or in refinancing our obligations on favorable terms,
or at all. Should we determine to refinance, it could be dilutive to stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I></I></B></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Provisions in our Certificate
of Incorporation and Bylaws and provisions under Delaware law could make it more difficult for a third party to acquire us or increase
the cost of acquiring us, even if doing so would benefit our stockholders, and may prevent or frustrate attempts by our stockholders to
replace or remove our current management.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some provisions of our charter
documents may have anti-takeover effects that could discourage an acquisition of us by others, even if an acquisition would be beneficial
to our stockholders, and may prevent attempts by our stockholders to replace or remove our current management. These provisions include:
authorizing the issuance of &ldquo;blank check&rdquo; preferred stock, the terms of which may be established and shares of which may be
issued without stockholder approval; and establishing advance notice requirements for nominations for election to the board of directors
or for proposing matters that can be acted upon at stockholder meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These provisions may frustrate
or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to
replace members of our board of directors, which is responsible for appointing the members of our management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we are subject
to the provisions of Section 203 of the Delaware General Corporation Law (&ldquo;Section 203&rdquo;) regulating corporate takeovers. In
general, Section 203 prohibits publicly held Delaware corporation from engaging in a business combination with an interested stockholder
(generally, any entity, person or group beneficially owning 15% or more of the outstanding voting stock of the company) for a period of
three years after the date of the transaction in which the person became an interested stockholder, unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, (1) shares owned by persons who are directors and also officers and (2) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at or subsequent to the date of the transaction, the business combination is approved by the board and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not owned by the interested stockholder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This provision could have
the effect of delaying or preventing a change of control, whether or not it is desired by or beneficial to our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Risks Related to Our Cryptocurrency Assets Treasury
Strategy and Holdings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">See our Registration Statement on Form S-3, Amendment
No. 1, filed with the SEC on August 26, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="live_006"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of the Securities offered
by the Selling Stockholders pursuant to this prospectus will be sold by the Selling Stockholders for their respective accounts. We will
not receive any of the proceeds from the sale or other disposition of the Securities by the Selling Stockholders. However, we will receive
proceeds from the exercise of the Warrants if the Warrants are exercised and the holders of such Warrants pay the exercise price in cash
upon such exercise and do not utilize the cashless exercise provision of the Warrants. The Warrants are exercisable on a net exercise
cashless basis or for cash at the option of the holder. If any of the Warrants are exercised on a cashless basis, we will not receive
any cash payment from the applicable Selling Stockholder upon any such exercise. Assuming the exercise in full of all such Warrants for
cash, we will receive up to an aggregate of approximately $30,000 from the exercise of all of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to use our net proceeds
from the cash exercised of the Warrants, if any, for general corporate purposes, to support commercial operations, working capital, repayment
of indebtedness and for potential acquisitions. The amounts and timing of any expenditures will vary depending on the amount of cash generated
by the cash exercise of the Warrants, if any, and our plans and business conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will bear all other costs,
fees and expenses incurred in effecting the registration of the warrants (including shares of common stock underlying such warrants) covered
by this prospectus. All selling and other expenses incurred by the Selling Stockholders will be borne by the Selling Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">See &ldquo;Selling Stockholders&rdquo; and &ldquo;Plan
of Distribution&rdquo; described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="live_007"></A><B>BACKGROUND OF THE OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">See &ldquo;Selling Stockholders
&#11834; Material Transactions with the Selling Stockholders&rdquo; described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="live_008"></A>SELLING STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities being offered
by the Selling Stockholders include: (i) 3,000,000 shares of our common stock, (ii) Warrants to purchase up to an aggregate of 3,000,000
shares of our common stock, and (iii) up to 3,000,000 Warrant Shares issuable upon the exercise of the Warrants. For additional information
regarding the issuance of the Securities, see &ldquo;&#11834; Material Transactions with the Selling Stockholders&rdquo; described below.
We are registering the Securities in order to permit the Selling Stockholders to offer the Securities for resale from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used in this prospectus,
the term &ldquo;Selling Stockholders&rdquo; includes the selling stockholders listed in the table below, together with any additional
selling stockholders listed in a subsequent amendment or supplement to this prospectus, and their donees, pledgees, assignees, transferees,
distributees or other successors-in-interest that receive any Securities in any non-sale transfer after the date of this prospectus. None
of the Selling Stockholders or any persons having control over such Selling Stockholders has held any position or office with us or our
affiliates within the last three years or has had a material relationship with us or any of our predecessors or affiliates within the
past three years except as described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below lists the
Selling Stockholders and other information regarding the beneficial ownership (as determined under Section 13(d) of the Securities Exchange
Act of 1934, as amended, or the &ldquo;<I>Exchange Act</I>,&rdquo; and the rules and regulations thereunder) of the shares of our common
stock by each of the Selling Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The second column lists the
number of shares of our common stock beneficially owned by each Selling Stockholder ownership before this offering&nbsp;(including shares
of our common stock or any other securities of our Company which the Selling Stockholder has the right to acquire within 60 days, including
upon conversion of any convertible securities), based on its ownership of the Securities, as of August 22, 2025, assuming exercise of
the Warrants held by the Selling Stockholders on that date, without regard to any limitations on conversions or exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third column lists the
shares of our common stock being offered by this prospectus by the Selling Stockholders and does not take in account any limitations on
the exercise of the Warrants set forth therein. As a result of such limitations, the shares of common stock offered by this prospectus
may exceed the number of shares of common stock beneficially owned by the Selling Stockholders as of August 22, 2025. In accordance with
the terms of the Letter Agreements with the Selling Stockholders, this prospectus generally covers the resale of at least 100% of the
number of the shares of our common stock issuable pursuant to the exercise of the Warrants as of the trading day immediately preceding
the date the registration statement is initially filed with the SEC. Because the exercise price of the Warrants may be adjusted (in the
event of any stock split, stock dividend, stock combination, recapitalization or other similar transaction), the number of shares of our
common stock that will actually be issued may be more or less than the number of shares being offered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fourth and fifth columns
list the number of shares of common stock beneficially owned by the Selling Stockholders and their percentage ownership after the offering
shares of common stock (including shares which the Selling Stockholder has the right to acquire within 60 days, including upon conversion
of any convertible securities), assuming the sale of all of the securities offered by the Selling Stockholders pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The amounts and information
set forth below are based upon information provided to us by the Selling Stockholders as of August 22, 2025, except as otherwise noted
below. The Selling Stockholders may sell all or some of the shares of common stock it is offering, and may sell, unless indicated otherwise
in the footnotes below, shares of our common stock otherwise than pursuant to this prospectus. The tables below assume the Selling Stockholders
sell all of the shares offered by them in offerings pursuant to this prospectus, and not acquire any additional shares. We are unable
to determine the exact number of shares that will actually be sold or when or if these sales will occur. See &ldquo;<I>Plan of Distribution</I>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold">Name of Selling Stockholder</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares<BR> Owned<BR> Prior to<BR> Offering(1)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maximum <BR> Number<BR> of Shares to<BR> be Sold<BR> Pursuant<BR> to this<BR> Prospectus</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares<BR> Owned After<BR> Offering</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percentage&nbsp;of<BR> Shares<BR> Beneficially<BR> Owned After<BR> Offering(2)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left; padding-left: 0.25pt">Harvest Small Cap Partners, L.P.(3)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,188,088</TD><TD STYLE="width: 1%; text-align: left">(4)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,798,428</TD><TD STYLE="width: 1%; text-align: left">(5)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">389,660</TD><TD STYLE="width: 1%; text-align: left">(6)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">*</TD><TD STYLE="width: 1%; text-align: left"></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25pt">Harvest Small Cap Partners Master, Ltd.(3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,111,912</TD><TD STYLE="text-align: left">(7)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,201,572</TD><TD STYLE="text-align: left">(8)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">910,340</TD><TD STYLE="text-align: left">(9)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
less than 1%.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership includes shares of our common stock as to which a person or group has sole or shared voting power or dispositive power. Subject to the blocker described below, shares of our common stock registered hereunder are convertible within 60 days of August 22, 2025, are deemed outstanding for purposes of computing the number of shares beneficially owned and percentage ownership of the person holding such convertible securities, but are not deemed outstanding for computing the percentage of any other person.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentages are based on 115,413,332 shares of common stock outstanding as of August 22, 2025.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey Osher has voting and dispositive power over shares held by each of Harvest Small Cap Partners, L.P. and Harvest Small Cap Partners Master, Ltd. shown above. The address for each of Harvest Small Cap Partners, L.P. and Harvest Small Cap Partners Master, Ltd. is 505 Montgomery Street, Suite 1250, San Francisco, CA 94111.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents (i) 899,214 shares of our common stock beneficially owned by such Selling Stockholder as of August 22, 2025 (excluding our warrants beneficially owned by such Selling Stockholder), (ii) 389,660 shares of our common stock issuable to such Selling Stockholder upon the exercise of the warrants issued to such Selling Stockholder not being registered for resale hereby, and (iii) 899,214 shares of our common stock issuable to such Selling Stockholder upon the exercise of the Warrants issued to such Selling Stockholder Warrants being registered for resale hereby.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents (i) 899,214 shares of our common stock beneficially owned by such Selling Stockholder as of August 22, 2025 (excluding our warrants beneficially owned by such Selling Stockholder), and (ii) 899,214 shares of our common stock issuable to such Selling Stockholder upon the exercise of the Warrant issued to such Selling Stockholder, in each case being registered for resale hereby. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents 389,660 shares of our common stock issuable to such Selling Stockholder upon the exercise of the warrants issued to such Selling Stockholder not being registered for resale hereby, and assumes the sale of the maximum number of Securities to be sold pursuant to this prospectus.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents of (i) 2,100,786 shares of our common stock beneficially owned by such Selling Stockholder as of August 22, 2025 (excluding our warrants beneficially owned by such Selling Stockholder), (ii) 910,340 shares of our common stock issuable to such Selling Stockholder upon the exercise of the warrants issued to such Selling Stockholder not being registered for resale hereby, and (iii) 2,100,786 shares of our common stock issuable to such Selling Stockholder upon the exercise of the Warrants issued to such Selling Stockholder being registered for resale hereby.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents (i) 2,100,786 shares of our common stock beneficially owned by such Selling Stockholder as of August 22, 2025 (excluding our warrants beneficially owned by such Selling Stockholder), and (ii) 2,100,786 shares of our common stock issuable to such Selling Stockholder upon the exercise of the Warrants issued to such Selling Stockholder, in each case being registered for resale hereby.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents 910,340 shares of our common stock issuable to such Selling Stockholder upon the exercise of the warrants issued to such Selling Stockholder not being registered for resale hereby, and assumes the sale of the maximum number of Securities to be sold pursuant to this prospectus.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I>&nbsp;&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I></I></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Material Transactions with the Selling
Stockholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Amendment to Notes Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 8, 2021, we entered
into an amendment of notes agreement (collectively, the &ldquo;Amendments&rdquo;) with each of the Selling Stockholders of their subordinated
8.5% Secured Convertible Notes, originally issued to the Selling Stockholders on September 15, 2020, in the aggregate principal amount
of $15.0 million (the &ldquo;Notes&rdquo;) agreed to, among other things, (i) extend the maturity date of the Notes to June 3, 2023, (ii)
defer the June 30, 2022 quarterly cash interest payment to July 18, 2022, and defer the quarterly cash interest payment for the fiscal
quarter ending September 30, 2022 to be due and payable at the same time as the quarterly cash interest payment due and payable to the
Selling Stockholders for the fiscal quarter ending December 31, 2022, and (iii) permit us to prepay the Notes at any time without any
repayment/prepayment penalties and without the written consent of the Selling Stockholders, subject to approval from our senior secured
lender, provided, that we shall give the Selling Stockholders at least five days prior written notice of any such prepayment or repayment
(collectively, &ldquo;Loan Modification&rdquo;). We and the Selling Stockholders also agreed that if (i) at least $5,000,000 of the original
principal amount of the Notes was not repaid by us on or prior to January 1, 2023, the conversion price of the Notes shall be amended
to $3.00 per share, and we shall issue to the Selling Stockholders in aggregate an additional 250,000 shares of our common stock; (ii)
at least $7,500,000 of the original principal amount of the Notes is not repaid by us on or prior to June 30, 2023, the conversion price
of the Notes shall be further amended to $2.50 per share, and we shall then issue to the Selling Stockholders in aggregate an additional
500,000 shares of common stock; and (iii) the entire principal amount of the Notes then outstanding is not repaid by us on or prior to
January 1, 2024, the conversion price of the Notes shall be further amended to $2.25 per share, and we shall then issue to the Selling
Stockholders in aggregate an additional 750,000 shares of common stock. In addition, in consideration of the Loan Modification, we issued
to the Selling Stockholders in aggregate 500,000 shares of common stock. The shares were issued and to the extent applicable, will be
issued, to the Selling Stockholders as restricted securities in a private placement transaction exempt from the registration requirements
of the Securities Act.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>February 2023 Exchange
Agreements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 3, 2023 (the &ldquo;2023
Effective Date&rdquo;), we entered into an exchange agreement (collectively, the &ldquo;Exchange Agreements&rdquo;) with each of the Selling
Stockholders pursuant to which they exchanged their Notes, and relinquished any and all rights thereunder, for 21,177 shares of Series
A Preferred Stock. The Series A Preferred Stock is convertible at any time at a holder&rsquo;s option into shares of&nbsp;our common stock,
at a price of $2.10 per share of common stock, bears a dividend of 12% per annum, is perpetual and has no maturity date. At our option,
the dividend may be paid in-kind for the first 12 months after the 2023 Effective Date, and thereafter, at the time the Holders had the
option to select whether subsequent dividend payments shall be paid in kind or in cash; provided, that as long as any Series A Preferred
Stock is held by the Selling Stockholders, Trinad Capital Master Fund Ltd., a fund controlled by Mr. Ellin, our Chief Executive Officer,
Chairman, director and principal stockholder (&ldquo;Trinad Capital&rdquo;), shall receive the dividend solely in kind. The Series A Preferred
Stock shall have no voting rights, except as set forth in the Certificate of Designation (as defined below) or as otherwise required by
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Without the prior express
consent of the majority of the votes entitled to be cast by the holders of Series A Preferred Stock outstanding at the time of such vote
(the &ldquo;Majority Holders&rdquo;), we shall not authorize or issue any additional or other shares of its capital stock that are (i)
of senior rank to the Series A Preferred Stock or (ii) of pari passu rank to the Series A Preferred Stock, in each case in respect of
the preferences as to dividends, distributions and payments upon the liquidation, dissolution and winding up of our Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Exchange Agreements,
we agreed that at any time that any of the shares of Series A Preferred Stock issued to the Harvest Funds are outstanding, (i) to directly
or through its 100% owned subsidiaries (as applicable), to own on a fully diluted basis at least 66% of the total equity and voting rights
of any and all classes of securities of each of our PodcastOne, Inc. (&ldquo;PodcastOne&rdquo;), Slacker, Inc., PPV One, Inc., and LiveXLive
Events, LLC subsidiaries, (ii) not to issue shares of its common stock or convertible equity securities at a price less than $2.10 per
share (subject to certain exceptions), provided, that such consent shall not be required in connection with any merger, acquisition or
other business combinations of our Company and/or any of its subsidiaries with any unaffiliated third party, (iii) not to raise more than
an aggregate of $20,000,000 of capital in one or more offerings, including without limitation, one or more equity or debt offerings or
a combination thereof, on an accumulated basis commencing after the 2023 Effective Date (the &ldquo;Qualified Offering&rdquo;); provided,
that such consent shall not be required for any equity financing of our Company at a price of $2.25 per share or above, and (iv) if after
the 2023 Effective Date we distribute any of our assets or any shares of our common stock or Common Stock Equivalents (as defined in the
Exchange agreements) of any of our subsidiaries pro rata to the record holders of any class of shares of its common stock, we shall distribute
to the Selling Stockholders their pro rata portion of any such distribution (calculated on an as-converted basis with respect to the then
outstanding Series A Preferred Stock) concurrently with the distribution to the then record holders of any class of our common stock (including
an applicable distribution of shares of PodcastOne&rsquo;s common stock to the Selling Stockholders in connection with the Spin-Out and
special dividend of PodcastOne&rsquo;s common stock to our stockholders of record), in each case without the Majority Holders&rsquo; prior
written consent. Any breach of the aforementioned covenants or the terms of the Ellin Letter (as defined below) shall constitute a material
breach, which if uncured, shall result in the issuance of an aggregate of 56,473 shares of our restricted common stock (the &ldquo;Default
Shares&rdquo;) to the Holders for each five trading days (or pro rata thereof) after the date of the breach; provided, that if such breach
is cured within the applicable cure period, no Default Shares shall be issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration for entry
into the Exchange Agreements and the Selling Stockholders&rsquo; willingness to forego certain rights to common stock of our Company previously
agreed by the parties, we issued to the Selling Stockholders an aggregate of 600,000 shares of our common stock (the &ldquo;Harvest Shares&rdquo;).
Additionally, we issued 25,000 shares of common stock to the Selling Stockholders as consideration for their previously agreeing to extend
interest payment dates on the HSCPM Note and the HSCP Note (the &ldquo;Extension Shares&rdquo;). In connection with and as a condition
to the entry of the Exchange Agreements, pursuant to a letter agreement with us, the Selling Stockholders and Mr. Ellin (the &ldquo;Ellin
Letter&rdquo;), unless otherwise agreed to by the Selling Stockholders, Mr. Ellin agreed to (i) to serve as our Chief Executive Officer
and (ii) extend the period during which he cannot dispose of any equity or convertible securities of our Company owned by him or any entity
of which he is the beneficial owner and not to cease to be the beneficial owner of any other equity or convertible securities of our Company
of which Mr. Ellin is the beneficial owner (subject to certain exceptions), in each case until the time that the Selling Stockholders
no longer own any shares of the Series A Preferred Stock. The Harvest Shares, the Extension Shares and the Series A Preferred Stock were
issued, and the shares of common stock underlying the shares of Series A Preferred Stock, to the extent applicable, would be issued, to
the Holders as restricted securities in a private placement transaction exempt from the registration requirements of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>April 2024 Letter Agreements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 1, 2024, we entered
into the Letter Agreements with the Selling Stockholders pursuant to which (i) the Selling Stockholders converted approximately $8.72
million worth of their shares of Series A Preferred Stock into shares of our common stock at a price of $2.10 per share, as follows: HSCPM
converted 5,602.09 shares of Series A Preferred Stock into 2,667,664 shares of our common stock, and HSCP converted 2,397.91 shares of
Series A Preferred Stock into 1,141,860 shares of our common stock, and (ii) HSCPM and HSCP received 910,340 and 389,660 the Warrants
exercisable at a price of $2.10 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, pursuant to the
Letter Agreements, the Selling Stockholders agreed (x) that any future dividends payable on the Series A Preferred Stock shall be paid
in-kind or in cash at the option of our Company; provided, that as long as any Series A Preferred Stock is held by the Selling Stockholders,
Trinad Capital shall receive the dividend solely in kind, (y) to remove the requirement for us to purchase from the Selling Stockholders
$5,000,000 in aggregate of the then outstanding shares of Series A Preferred Stock held by the Selling Stockholders on or before August
3, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>July 2025 Letter Agreements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 15, 2025 (the &ldquo;Effective
Date&rdquo;), we entered into letter agreements (collectively, the &ldquo;Agreements&rdquo;) with the Harvest Funds. Pursuant to the Agreements:
(i) the Harvest Funds exchanged $4,500,000 worth of its shares of Series A Preferred Stock into 3,000,000 shares of common stock, at a
price of $1.50 per share, and (ii) the Harvest Funds received 3,000,000 <FONT STYLE="background-color: white">three-year Warrants to purchase
our common stock exercisable at a price of $0.01 per share</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Shares and the Warrants
were issued, and the Warrant Shares, to the extent exercised, will be issued, to the Holders as restricted securities in a private placement
transaction exempt from the registration requirements of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We further agreed, on or prior
to the date that is 45 days after the Effective Date, to prepare and file with the SEC a Registration Statement on Form S-3 (or such other
form as applicable) covering the resale under the Securities Act of the Shares, the Warrants and the Warrant Shares. We agreed to use
commercially reasonable best efforts to cause such registration statement to be declared effective promptly thereafter on or before 45
days after the filing of such registration statement (or if the SEC issues any comments with respect to such registration statement, on
or before 90 days after the filing of such registration statement). Upon effectiveness of such Registration Statement, we agreed to use
reasonable best efforts to keep the Registration Statement effective with the SEC for a period equal to three years from the Effective
Date for the Warrants, and with respect to the Shares and the Warrant Shares, so long as any Warrants or Shares are outstanding or held
by Holder, as applicable, and to supplement, amend and/or re-file such Registration Statement to comply with such effectiveness requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B></B></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="live_009"></A>DESCRIPTION OF SECURITIES WE ARE OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description
of our capital stock and provisions of our Certificate of Incorporation and Bylaws are summaries and are qualified by reference to the
Certificate of Incorporation and Bylaws that are on file with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Certificate of Incorporation
authorizes us to issue up to 10,000,000 shares of preferred stock, $0.001 par value per share, and 500,000,000 shares of our common stock,
$0.001 par value per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of August 22, 2025, there
were 115,413,332 and 7,886.07 shares of our common stock and preferred stock (including accrued dividends as of such date) issued and
outstanding, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of August 22, 2025, we
had 400 holders of record of our common stock, which excludes stockholders whose shares were held in nominee or street name by brokers.
The actual number of common stockholders is greater than the number of record holders and includes stockholders who are beneficial owners,
but whose shares are held in street name by brokers and other nominees. This number of holders of record also does not include stockholders
whose shares may be held in trust by other entities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Voting</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of our common stock
are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders, including the election
of directors, and do not have cumulative voting rights. Accordingly, the holders of a majority of the shares of our common stock entitled
to vote in any election of directors can elect all of the directors standing for election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Dividends</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to preferences that
may be applicable to any then outstanding preferred stock, the holders of common stock are entitled to receive dividends, if any, as may
be declared from time to time by our board of directors out of legally available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Liquidation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of our liquidation,
dissolution or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution
to stockholders after the payment of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference
granted to the holders of any outstanding shares of preferred stock.<B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Rights and Preferences</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of our common stock
have no preemptive, conversion or subscription rights, and there are no redemption or sinking fund provisions applicable to our common
stock. The rights, preferences and privileges of the holders of our common stock are subject to, and may be adversely affected by, the
rights of the holders of shares of any series of our preferred stock that we may designate and issue in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Fully Paid and Nonassessable</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of our outstanding shares
of common stock are, and the shares of common stock to be issued in this offering will be, fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors has
the authority, without further action by the stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series,
to establish from time to time the number of shares to be included in each such series, to fix the rights, preferences and privileges
of the shares of each wholly unissued series and any qualifications, limitations or restrictions thereon and to increase or decrease the
number of shares of any such series, but not below the number of shares of such series then outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors may
authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights
of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions
and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in our control
that may otherwise benefit holders of our common stock and may adversely affect the market price of the common stock and the voting and
other rights of the holders of common stock. As of August 22, 2025, there were 7,886.07 shares of our preferred stock outstanding (including
accrued dividends as of such date), and except for the dividends payable in kind on our Series A Preferred Stock (as defined below), we
have no current plans to issue any other shares of our preferred stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Series&nbsp;A Perpetual
Convertible Preferred Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 2, 2023, we filed
the Certificate of Designation (the &ldquo;Certificate of Designation&rdquo;) with the Secretary of State of the State of Delaware designating
100,000 shares of our preferred stock as &ldquo;Series&nbsp;A Perpetual Convertible Preferred Stock&rdquo; (the &ldquo;Series A Preferred
Stock&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Series A Preferred Stock was issued effective as of February 3, 2023, and is subsequently issued as quarterly dividends as required by
its terms, to the Selling Stockholders and Trinad Capital, a fund controlled by Robert Ellin, our Chief Executive Officer, Chairman, director
and principal stockholder, in exchange for certain indebtedness exchanged for such Series A Preferred Stock, as more fully discussed above.
An amendment to, or waiver of rights of, the Series A Preferred Stock requires the approval of the majority of the votes entitled to be
cast by the holders of Series A Preferred Stock outstanding at the time of such vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Voting</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of the shares
of the Series A Preferred Stock have certain voting rights as described in the Certificate of Designation equal to 1,000 votes per share
of Series A Preferred Stock. The holders of Series A Preferred Stock are not entitled to vote separately as a class or series on any amendment,
modification or restatement of the Certificate of Incorporation, except as would be unlawful under the laws of the State of Delaware or
except as required by Section 4 of the Certificate of Designation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Dividends</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
holders of the Series A Preferred Stock are entitled to receive, and we shall pay, by issuing shares of Series A Preferred Stock or paying
in cash to such holders, subject to and as provided in Section 3 of the Certificate of Designation, dividends on each share of Series
A Preferred Stock, based on a stated value per share equal to $1,000 (the &ldquo;Stated Value&rdquo;), at a rate of 12% per annum (the
&ldquo;Interest&rdquo;), commencing on February 3, 2023 (the &ldquo;Original Issue Date&rdquo;) until the date that such share of Series
A Preferred Stock is converted to our common stock (the &ldquo;Interest Termination Date&rdquo;). So long as a holder&rsquo;s shares of
Series A Preferred Stock are outstanding, Interest payments shall accrue and be compounded daily on the basis of a 360-day day year and
twelve 30-day months and shall be paid in arrears to such holder on the earlier of the following dates (i) the Interest Termination Date
and (ii) quarterly on April 1st, July 1st, October 1st and January 1st of each year (each such date, an &ldquo;Interest Payment Date&rdquo;).
At our option, the Interest payments may be made in shares of Series A Preferred Stock valued at a price per share equal to the Stated
Value (the &ldquo;Interest Shares&rdquo;); provided, that Trinad Capital shall receive Interest payments solely in Interest Shares. In
addition, in the event we declare any distribution or dividend of any of our assets or any shares of capital stock of any of our subsidiaries
pro rata to the record holders of any class of shares of common stock, we shall calculate and distribute to each holder its pro rata portion
of any such distribution (calculated on an as-converted basis with respect to the shares of Series A Preferred Stock then outstanding
as of the record date set by us for such distribution or dividend) concurrently with the distribution to the then record holders of any
class of common stock. Except as provided in this Section 3, Section 5 and Section 7 of the Certificate of Designation, no other dividends
shall be paid on shares of the Series A Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As
provided in the Certificate of Designation, Interest in Interest Shares was paid effective as of April 1, 2023, and subsequently as quarterly
dividends, on the terms summarized above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Liquidation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of any liquidation,
dissolution or winding up of our Company, either voluntarily or involuntarily, the holders of the Series A Preferred Stock are entitled
to receive, prior and in preference to the holders of the Common Stock, a per share amount equal to the Stated Value plus any accrued
but unpaid Interest thereon, or the amount the holder would be entitled to receive if the Series A Preferred Stock were fully converted
(disregarding for such purposes any conversion limitations hereunder) to common stock which amounts shall be paid pari passu with all
holders of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If upon the liquidation, dissolution
or winding up of the Company, the assets of our Company that are legally available for distribution to the holders of the Series A Preferred
Stock are insufficient to permit the payment to such holders of the full amounts above, then the entire assets of our Company that are
legally available for distribution shall be distributed with equal priority and pro rata among the holders of the Series A Preferred Stock
in proportion to what they would otherwise be entitled to receive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Rights and Preferences</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the period any shares of Series A Preferred Stock remain outstanding, unless we have received the approval of the majority of the votes
entitled to be cast by the holders of Series A Preferred Stock outstanding at the time of such vote (voting together as a single class),
either at a meeting of holders of Series A Preferred Stock or by written consent, we shall not, either directly or indirectly by amendment,
merger, consolidation, recapitalization, reclassification, or otherwise, do any of the following without (in addition to any other vote
required by law), and any such&nbsp;act or transaction entered into without such consent or vote shall be null and void&nbsp;<I>ab initio</I>,
and of no force or effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase the number of authorized shares of Series A Preferred Stock&#894;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">issue or obligate itself to issue additional shares Series A Preferred Stock other than Interest Shares; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">amend, alter or repeal any provision of the Certificate of Designation;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">amend, alter or repeal any provision of the Certificate of Incorporation or other charter documents in a manner that adversely affects the powers, preferences or rights of the Series A Preferred Stock or in any manner that adversely affects any rights of the Holders; or</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enter into any agreement with respect to the foregoing.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">For
purposes of the foregoing voting requirements, the increase in the amount of the authorized preferred stock (other than Series A Preferred
Stock) or common stock, or the creation or issuance of any other series of Preferred Stock or common stock that we may issue, or any increase
in the amount of authorized shares of such series, shall not in itself be deemed to materially and adversely affect the rights, preferences
or voting powers of the Series A Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><I>Conversion</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Each
share of Series A Preferred Stock is convertible, at the option of the holder, at any time after the date of issuance of such share, into
such number of fully paid and&nbsp;non-assessable&nbsp;shares of common stock determined by multiply the number of Series A Preferred
Stock by the Stated Value and dividing the product thereof by the conversion price for such series in effect at the time of conversion
for the Series A Preferred Stock. The conversion price for the Series A Preferred Stock is subject to adjustment in accordance with conversion
provisions contained in the Certificate of Designations. As of June 24, 2024, the conversion price of the Series A Preferred Stock is
$2.10 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
will not effect the conversion of any portion of the shares of Series A Preferred Stock, and the holder will not have the right to convert
any shares of Series A Preferred Stock, and any such conversion shall be null and void and treated as if never made, to the extent that
after giving effect to such exercise, the holder together with its affiliates collectively would own beneficially in excess of 4.99% (or,
upon election by a holder prior to the issuance of any shares of Series A Preferred Stock, such beneficial ownership limitation may increase
or decrease) of the shares of common stock outstanding immediately after giving effect to such exercise. This limitation is not applicable
to any shares of Series A Preferred Stock held by Trinad Capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Authorized and Unissued Capital Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Delaware law does not require
stockholder approval for any issuance of authorized shares. These additional shares may be used for a variety of corporate purposes, including
future public offerings, to raise additional capital or to facilitate acquisitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">One of the effects of the
existence of unissued and unreserved common stock or preferred stock may be to enable our board of directors to issue shares to persons
friendly to current management, which issuance could render more difficult or discourage an attempt to obtain control of our company by
means of a merger, tender offer, proxy contest or otherwise, and thereby protect the continuity of our management and possibly deprive
the stockholders of opportunities to sell their shares at prices higher than prevailing market prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of August 22, 2025, there were 6,335,399
warrants outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2016 Plan Awards</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of August 22, 2025, we
have granted options, restricted stock units, and restricted share awards, to purchase in aggregate of approximately 2,631,830 shares
of our common stock under the 2016 Equity Incentive Plan, as amended, with a weighted average exercise price per share for outstanding
shares is $3.72 and the weighted average exercise price per share for exercisable shares is approximately $3.72 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Delaware Anti-Takeover Law and Certain Charter
and Bylaw Provisions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Delaware Anti-Takeover
Statute</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to the provisions
of Section 203 of the Delaware General Corporation Law regulating corporate takeovers. In general, Section 203 prohibits a publicly held
Delaware corporation from engaging, under certain circumstances, in a business combination with an interested stockholder for a period
of three years following the date the person became an interested stockholder unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prior to the date of the transaction, our board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, (1) shares owned by persons who are directors and also officers and (2) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at or subsequent to the date of the transaction, the business combination is approved by our board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not owned by the interested stockholder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Generally, a business combination
includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. An interested
stockholder is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested
stockholder status, did own 15% or more of a corporation&rsquo;s outstanding voting stock. We expect the existence of this provision to
have an anti-takeover effect with respect to transactions our board of directors does not approve in advance. We also anticipate that
Section 203 may discourage attempts that might result in a premium over the market price for the shares of common stock held by stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The provisions of Delaware
law and the provisions of our Certificate of Incorporation and Bylaws could have the effect of discouraging others from attempting hostile
takeovers and, as a consequence, they might also inhibit temporary fluctuations in the market price of our common stock that often result
from actual or rumored hostile takeover attempts. These provisions might also have the effect of preventing changes in our management.
It is also possible that these provisions could make it more difficult to accomplish transactions that stockholders might otherwise deem
to be in their best interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Bylaws</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Provisions of our Bylaws may
delay or discourage transactions involving an actual or potential change in our control or change in our management, including transactions
in which stockholders might otherwise receive a premium for their shares or transactions that our stockholders might otherwise deem to
be in their best interests. Therefore, these provisions could adversely affect the price of our common stock. Among other things, our
Bylaws:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">permit our board of directors to issue up to 10,000,000 shares of preferred stock, with any rights, preferences and privileges as they may designate (including the right to approve an acquisition or other change in our control);</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide that the authorized number of directors may be changed only by resolution of the board of directors;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">do not provide for cumulative voting rights (therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The amendment of any of these
provisions, with the exception of the ability of our board of directors to issue shares of preferred stock and designate any rights, preferences
and privileges thereto, would require approval by the holders of a majority of our then outstanding common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is listed
on The Nasdaq Capital Market under the symbol &ldquo;LVO.&rdquo; The Warrants are not listed on Nasdaq, any national securities exchange
or any other nationally recognized trading system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The transfer agent and registrar
for our common stock is VStock Transfer, LLC. We serve as the registrar for the Warrants. The transfer agent and registrar&rsquo;s address
is 18 Lafayette Place, Woodmere, NY 11598.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="live_010"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are registering (i) 3,000,000
shares of our common stock, (ii) Warrants to purchase up to an aggregate of 3,000,000 shares of our common stock, and (iii) up to 3,000,000
Warrant Shares issuable upon the exercise of the Warrants issued to the Selling Stockholders, and without taking into account the limitations
on the exercise of the Warrants set forth in the Warrants, to permit the resale of these Securities by the holders thereof from time to
time after the date of this prospectus. We will not receive any of the proceeds from the sale or other disposition of the Securities by
the Selling Stockholders. However, we will receive proceeds from the exercise of the Warrants if the Warrants are exercised and the holders
of such Warrants pay the exercise price in cash upon such exercise and do not utilize the cashless exercise provision of the Warrants.
Assuming the exercise in full of all such Warrants for cash, we will receive up to an aggregate of approximately $30,000 from the exercise
of all of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of the Securities
(and any of their pledgees, assignees and successors-in-interest (the &ldquo;Selling Stockholders&rdquo;) may, from time to time, sell
any or all of their shares of common stock on any stock exchange, market or trading facility on which the shares are traded or in private
transactions. These sales may be at fixed or negotiated prices. The Selling Stockholders may use any one or more of the following methods
when selling shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately negotiated transactions;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">broker-dealers may agree with the Selling Stockholders to sell a specified number of such shares at a stipulated price per share;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a combination of any such methods of sale; or</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders may
also sell shares under Rule 144 under the Securities Act, if available, rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the sale
of our common stock or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume. The Selling
Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one
or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this
prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or
amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders and
any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act. Each Selling Stockholder has informed us that it does not have any written or oral agreement or understanding, directly or indirectly,
with any person to distribute the securities. Any compensation paid to underwriters, broker-dealers or agents in connection with the offering
of the securities, and any discounts, concessions or commissions allowed by underwriters to participating dealers will be provided in
the applicable prospectus supplement and shall comply with the rules and requirements of the FINRA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are required to pay certain
fees and expenses incurred by us incident to the registration of these shares, estimated to be approximately $50,000 in total, including,
without limitation, SEC filing fees and expenses of compliance with state securities or &ldquo;blue sky&rdquo; laws; provided, however,
that the Selling Stockholders will pay all underwriting discounts and selling commissions, if any. We have agreed to indemnify the Selling
Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because Selling Stockholders
may be deemed to be &ldquo;underwriters&rdquo; within the meaning of the Securities Act, they will be subject to the prospectus delivery
requirements of the Securities Act including Rule 172 thereunder. In addition, any securities covered by this prospectus which qualify
for sale pursuant to Rule 144 under the Securities Act may be sold under Rule 144 rather than under this prospectus. There is no underwriter
or coordinating broker acting in connection with the proposed sale of the resale shares by the Selling Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We agreed to keep this prospectus
effective (i) with respect to the Warrants, until July 15, 2028, and (ii) with respect to the Warrant Shares, so long as any Warrants
are outstanding, and to supplement, amend and/or re-file the registration statement of which this prospectus is a part to comply with
such effectiveness requirement. The Securities shares will be sold only through registered or licensed brokers or dealers if required
under applicable state securities laws. In addition, in certain states, the Securities may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied
with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There can be no assurance
that any Selling Stockholder will sell any or all of their Warrants (or Warrant Shares underlying the Warrants) registered pursuant to
the registration statement of which this prospectus forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the Securities may not simultaneously engage in market making
activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement
of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules
and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of shares of the common stock by
the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed
them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with
Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Once sold pursuant to this
prospectus, the Warrants (or Warrant Shares underlying the Warrants if such Warrant Shares are sold) will be freely tradable in the hands
of persons other than our affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="live_011"></A><B>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The validity of the securities
being offered by this prospectus has been passed upon by Foley Shechter Ablovatskiy LLP (&ldquo;FSA&rdquo;). Certain of FSA&rsquo;s partners
own shares of our common stock, which represent, in the aggregate, beneficial ownership of less than 1.0 % of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="live_012"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements of LiveOne, Inc. as of March 31, 2025 and 2024 and for each of the two years in the period ended March 31, 2025 incorporated
by reference in this Prospectus have been so incorporated in reliance on the report of Macias Gini &amp; O&rsquo;Connell LLP, an independent
registered public accounting firm (the report on the consolidated financial statements contains an explanatory paragraph regarding the
Company&rsquo;s ability to continue as a going concern), incorporated herein by reference, given on the authority of said firm as experts
in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="live_013"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is part of
a registration statement on Form S-3 that we have filed with the SEC relating to the shares of our securities being offered hereby. This
prospectus does not contain all of the information in the registration statement and its exhibits. The registration statement, its exhibits
and the documents incorporated by reference in this prospectus and their exhibits, all contain information that is material to the offering
of the securities hereby. Whenever a reference is made in this prospectus to any of our contracts or other documents, the reference may
not be complete. You should refer to the exhibits that are a part of the registration statement in order to review a copy of the contract
or documents. The registration statement and the exhibits are available through the SEC&rsquo;s website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We file annual, quarterly
and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet
at the SEC&rsquo;s website at www.sec.gov and on our website at www.liveone.com. The information found on, or that can be accessed from
or that is hyperlinked to, our website is not part of this prospectus or any applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will provide you without
charge, upon your oral or written request, with a copy of any or all reports, proxy statements and other documents we file with the SEC,
as well as any or all of the documents incorporated by reference in this prospectus or the registration statement (other than exhibits
to such documents unless such exhibits are specifically incorporated by reference into such documents). Requests for such copies should
be directed to LiveOne, Inc., 269 South Beverly Drive, Suite 1450, Beverly Hills, CA 90212, Attention: Corporate Secretary, telephone
number (310) 601-2505.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should rely only on the
information in this prospectus and the additional information described above and under the heading &ldquo;Incorporation of Certain Information
by Reference&rdquo; below. We have not authorized any other person to provide you with different information. If anyone provides you with
different or inconsistent information, you should not rely upon it. We are not making an offer to sell these securities in any jurisdiction
where the offer or sale is not permitted. You should assume that the information in this prospectus was accurate on the date of the front
cover of this prospectus only. Our business, financial condition, results of operations and prospects may have changed since that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="live_014"></A><B>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate
by reference&rdquo; information that we file with them. Incorporation by reference allows us to disclose important information to you
by referring you to those other documents. The information incorporated by reference is an important part of this prospectus, and information
that we file later with the SEC will automatically update and supersede this information. This prospectus omits certain information contained
in the registration statement, as permitted by the SEC. You should refer to the registration statement, including the exhibits, for further
information about us and the securities we may offer pursuant to this prospectus. Statements in this prospectus regarding the provisions
of certain documents filed with, or incorporated by reference in, the registration statement are not necessarily complete and each statement
is qualified in all respects by that reference. Copies of all or any part of the registration statement, including the documents incorporated
by reference or the exhibits, may be obtained upon payment of the prescribed rates at the offices of the SEC listed above in &ldquo;Where
You Can Find More Information.&rdquo; The documents we are incorporating by reference are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000143774925022739/lvo20250331_10k.htm">Form 10-K</A> for the fiscal year ended March 31, 2025, filed with the SEC on July &nbsp;15, 2025;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000143774925026903/lvo20250630_10q.htm">Form 10-Q</A> for the quarter ended June 30, 2025, filed with the SEC on August 14, 2025;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Current Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390025028683/ea0237125-8k_liveone.htm">Form 8-K</A>, filed with the SEC on April 3, 2025;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Current Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390025047412/ea0242972-8k_liveone.htm">Form 8-K</A>, filed with the SEC on May 23, 2025;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Current Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390025064338/ea0249091-8k_liveone.htm">Form 8-K</A>, filed with the SEC on July 15, 2025;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Current Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390025064904/ea0249283-8k_liveone.htm">Form 8-K</A>, filed with the SEC on July 17, 2025;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Current Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390025065188/ea0249441-8k_liveone.htm">Form 8-K</A>, filed with the SEC on July 17, 2025;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Current Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390025074328/ea0252597-8k_liveone.htm">Form 8-K</A>, filed with the SEC on August 11, 2025;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the information specifically incorporated by reference into our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000143774925022739/lvo20250331_10k.htm">Form 10-K</A> for the fiscal year ended March 31, 2025 from our definitive Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390025065220/ea0248124-02.htm">Schedule 14A</A>, filed with the SEC on July 17, 2025;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of our common stock contained in <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000143774925022739/ex_838319.htm">Exhibit 4.7</A> to our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000143774925022739/lvo20250331_10k.htm">Form 10-K</A> for the fiscal year ended March 31, 2025, filed with the SEC on July 15, 2025; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of our common stock contained in our Registration Statement on Form 8-A, filed on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390017010710/f8a12b1017_livexlivemedia.htm">October 19, 2017</A> and as amended on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390018002124/f8a12b0218a1_livexlive.htm">February 20, 2018</A>, pursuant to Section 12(b) of the Exchange Act, which incorporates by reference the description of the shares of our common stock contained in our Registration Statement on Form S-1 (Registration No. 333-217893) initially filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390017004949/fs12017_lotoncorp.htm">May 11, 2017</A>, as amended, and declared effective by the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390017013506/fs1122017a6_livexlive.htm">December 21, 2017</A>, and any amendment or report filed with the SEC for purposes of updating such description; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all reports and other documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this prospectus and prior to the termination or completion of the offering of securities under this prospectus, and also between the date of the initial registration statement and prior to effectiveness of the registration statement, shall be deemed to be incorporated by reference in this prospectus and to be a part hereof from the date of filing such reports and other documents; provided, however, that we are not incorporating any information furnished under any of Item 2.02 or Item 7.01 of any Current Report on Form 8-K.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
we are not incorporating any document or portion thereof or information deemed to have been furnished and not filed in accordance with
SEC rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Information in this prospectus
supersedes related information in the documents listed above, and information in subsequently filed documents supersedes related information
in each of this prospectus and the incorporated documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will promptly provide,
without charge to you, upon written or oral request, a copy of any or all of the documents incorporated by reference in this prospectus,
other than exhibits to those documents, unless the exhibits are specifically incorporated by reference in those documents. Requests should
be directed to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Corporate Secretary</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>LiveOne, Inc.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>269 South Beverly Drive, Suite 1450&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Beverly Hills, CA 90212</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You can also find these filings
on our website at&nbsp;<I>www.liveone.com</I>. We are not incorporating the information on our website other than these filings into this
prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>6,000,000 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrants to Purchase up to 3,000,000 Shares
of Common Stock </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIVEONE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Preliminary Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 14. Other Expenses of Issuance and Distribution.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The estimated expenses in
connection with the sale of the shares being registered hereby, all of which will be borne by the Company as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">SEC registration fee</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">537.12</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Legal fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounting fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Printing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Miscellaneous</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt; padding-left: 0.125in">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">50,537.12</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 15. Indemnification of Directors and Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;102 of the Delaware
General Corporation Law permits a corporation to eliminate the personal liability of its directors or its stockholders for monetary damages
for a breach of fiduciary duty as a director, except where the director breached his or her duty of loyalty, failed to act in good faith,
engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in
violation of Delaware corporate law or obtained an improper personal benefit. Our Certificate of Incorporation contains provisions that
limit the liability of our directors for monetary damages to the fullest extent permitted by Delaware law. Consequently, our directors
will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability
for:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any breach of the director&rsquo;s duty of loyalty to us or our stockholders;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law; or</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any transaction from which the director derived an improper personal benefit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;145 of the Delaware
General Corporation Law provides that a corporation has the power to indemnify a director, officer, employee, or agent of the corporation
and certain other persons serving at the request of the corporation in related capacities against expenses (including attorneys&rsquo;
fees), judgments, fines and amounts paid in settlements actually and reasonably incurred by the person in connection with an action, suit
or proceeding to which he or she is or is threatened to be made a party by reason of such position, if such person acted in good faith
and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action
or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that, in the case of actions brought by or in
the right of the corporation, no indemnification shall be made with respect to any claim, issue or matter as to which such person shall
have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court
determines that, despite the adjudication of liability but in view of all of the circumstances of the case, such person is fairly and
reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Certificate of Incorporation
and Bylaws provide that we are required to indemnify our directors and officers, in each case to the fullest extent permitted by Delaware
law. Our amended and restated bylaws also provide that we are obligated to advance expenses incurred by a director or officer in advance
of the final disposition of any action or proceeding, and permit us to secure insurance on behalf of any officer, director, employee or
other agent for any liability arising out of his or her actions in that capacity regardless of whether we would otherwise be permitted
to indemnify him or her under the provisions of Delaware law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The limitation of liability
and indemnification provisions in our Certificate of Incorporation and Bylaws may discourage stockholders from bringing a lawsuit against
our directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against our
directors and officers, even though an action, if successful, might benefit us and other stockholders. Further, a stockholder&rsquo;s
investment may be adversely affected to the extent that we pay the costs of settlement and damage awards against directors and officers
as required by these indemnification provisions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, in the future,
we may enter into indemnification agreements with our directors and officers and some of our executives may have certain indemnification
rights arising under their employment agreements with us. These indemnification agreements may require us, among other things, to indemnify
our directors and officers for some expenses, including attorneys&rsquo; fees, judgments, fines and settlement amounts incurred by a director
or officer in any action or proceeding arising out of his or her service as one of our directors or officers, or any of our subsidiaries
or any other company or enterprise to which the person provides services at our request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These indemnification provisions
and the indemnification agreements may be sufficiently broad to permit indemnification of our officers and directors for liabilities,
including reimbursement of expenses incurred, arising under the Securities Act. We have been advised that, in the opinion of the SEC,
indemnification of directors or officers for liabilities arising under the Securities Act is against public policy and, therefore, such
indemnification provisions may be unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain a general liability
insurance policy that covers certain liabilities of directors and officers of our corporation arising out of claims based on acts or omissions
in their capacities as directors or officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item 16.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibits</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: top; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
Number</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 91%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390017008330/f8k080217ex3i_livexlivemed.htm">Certificate of Incorporation of the Company (Incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on August 8, 2017).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390017010383/fs12017a3ex3-2_livexlivemed.htm">Certificate of Amendment to the Certificate of Incorporation of the Company, dated as of September 30, 2017 (Incorporated by reference to Exhibit 3.2 to the Company&rsquo;s&nbsp;Registration Statement on Form S-1, Amendment No. 3, filed with the SEC on October 6, 2017).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390017008330/f8k080217ex3ii_livexlivemed.htm">Bylaws of the Company (Incorporated by reference to Exhibit 3.2 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on August 8, 2017).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390021002268/ea133247ex3-1_livexlivemedia.htm">Amendment No. 1 to the Bylaws of the Company (Incorporated by&nbsp;reference to Exhibit 3.1 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on January 14, 2021).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390021052422/ea148634ex3-1_liveoneinc.htm">Certificate of Merger, dated as of September 30, 2021, between the Company and LiveOne, Inc. (Incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on October 12, 2021).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390022040403/ea163077ex4-2_liveone.htm">Form of Warrants, dated July 15, 2022, issued by PodcastOne to the purchasers of PodcastOne&rsquo;s 10% Original Issue Discount Convertible Promissory Notes, dated July 15, 2022 (Incorporated by reference to Exhibit 4.2 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on July 20, 2022).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390023008720/ea172780ex4-1_liveoneinc.htm">Certificate of Designation of Preferences, Rights and Limitations of Series A Perpetual Convertible Preferred Stock of the Company, dated as of February 2, 2023 (Incorporated by reference to Exhibit 4.1 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC February 7, 2023).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390024030849/ea020335801ex4-1_live.htm">Warrant to Purchase Common Stock, dated as of April 1, 2024, issued by the Company to Harvest Small Cap Partners, L.P. (Incorporated by reference to Exhibit 4.1 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC April 5, 2024).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390024030849/ea020335801ex4-2_live.htm">Warrant to Purchase Common Stock, dated as of April 1, 2024, issued by the Company to Harvest Small Cap Partners, Ltd. (Incorporated by reference to Exhibit 4.2 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC April 5, 2024).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390024030849/ea020335801ex4-3_live.htm">Warrant to Purchase Common Stock, dated as of April 1, 2024, issued by the Company to Trinad Capital Master Fund Ltd. (Incorporated by reference to Exhibit 4.3 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC April 5, 2024).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390025047412/ea024297201ex4-1_liveone.htm">Form of 11.75% Original Issue Discount Senior Secured Convertible Debentures (Incorporated by reference to Exhibit 4.1 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on May 23, 2025).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390025064338/ea024909101ex4-1_liveone.htm">Warrant to Purchase Common Stock, dated as of July 15, 2025, issued by the Company to Harvest Small Cap Partners, L.P. (Incorporated by reference to Exhibit 4.1 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on July 15, 2025).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390025064338/ea024909101ex4-2_liveone.htm">Warrant to Purchase Common Stock, dated as of July 15, 2025, issued by the Company to Harvest Small Cap Partners Master, Ltd. (Incorporated by reference to Exhibit 4.2 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on July 15, 2025).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390025064338/ea024909101ex4-3_liveone.htm">Warrant to Purchase Common Stock, dated as of July 15, 2025, issued by the Company to Trinad Capital Master Fund Ltd. (Incorporated by reference to Exhibit 4.3 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on July 15, 2025).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1491419/000121390025064904/ea024928301ex4-1_liveone.htm">Form of Underwriter&rsquo;s Warrant (Incorporated by reference to Exhibit 4.1 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on July 17, 2025).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea025507201ex5-1_liveone.htm">Opinion of Foley Shechter Ablovatskiy LLP regarding legality of securities being registered.</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea025507201ex23-1_liveone.htm">Consent of Macias Gini &amp; O&rsquo;Connell LLP, Independent Registered Public Accounting Firm.</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea025507201ex5-1_liveone.htm">Consent of Foley Shechter Ablovatskiy LLP (included in the opinion filed as Exhibit 5.1).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#live_015">Power of Attorney (included on the signature page of this registration statement).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea025507201ex-fee_liveone.htm">Filing Fee Table.</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&dagger;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management contract or compensatory plan or arrangement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 17. Undertakings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The undersigned registrant hereby undertakes:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">To file, during any period in which offers or sales are being
made, a post-effective amendment to this registration statement:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">(i) To include any prospectus required
by Section 10(a)(3) of the Securities Act of 1933;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">(ii) To reflect in the prospectus any
facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the
form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no
more than a 20 percent change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table
in the effective registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">(iii) To include any material information
with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information
in the registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Provided</I>,&nbsp;<I>however</I>,
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Paragraphs (1)(i), (1)(ii) and (1)(iii)
of this section do not apply if the registration statement is on Form S-3 and the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section
13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained
in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">That, for the purposes of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the termination of the offering.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(5)</TD><TD STYLE="text-align: justify">That, for the purpose of determining liability under the Securities
Act of 1933 to any purchaser:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b) The undersigned registrant hereby undertakes
that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&rsquo;s annual report
pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit
plan&rsquo;s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the
registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering
of such securities at that time shall be deemed to be the initial bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(h) Insofar as indemnification for liabilities
arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to
the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, hereunto duly authorized,
in Los Angeles, California on August 29, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LiveOne, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Robert S. Ellin</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert S. Ellin</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and <BR>
Chairman of the Board </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Ryan Carhart</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ryan Carhart</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer <BR>
(Principal Accounting Officer) </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="live_015"></A>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Each
person whose signature appears below hereby constitutes and appoints Robert S. Ellin and Ryan Carhart, and each of them severally, his
true and lawful&nbsp;attorneys-in-fact&nbsp;and agents, each with full power of substitution, for him and in his name, place and stead,
in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to
sign any registration statement for the same offering covered by this registration statement that is to be effective upon filing pursuant
to Rule 462(b) promulgated under the Securities Act of 1933, as amended, and all post-effective amendments thereto, and to file the same,
with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said&nbsp;attorneys-in-fact&nbsp;and
agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in
and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming that each
of said&nbsp;attorneys-in-fact&nbsp;and agents or any of them, or his or their substitute or substitutes, may lawfully do or cause to
be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates
indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 31%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 46%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 21%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Robert S. Ellin</I></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Chairman (Principal </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 29, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert S. Ellin</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Officer)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Ryan Carhart</I></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer,&nbsp;VP, Secretary and</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 29, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ryan Carhart</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasurer (Principal Accounting Officer)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Jay Krigsman</I></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 29, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay Krigsman</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Ramin Arani</I>&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 29, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ramin Arani&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Patrick Wachsberger</I></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 29, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrick Wachsberger</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Kenneth Solomon</I></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 29, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kenneth Solomon</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Bridget Baker</I></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 29, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridget Baker</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Kristopher Wright</I></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 29, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kristopher Wright</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 41; Options: NewSection Last; Value: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea025507201ex5-1_liveone.htm
<DESCRIPTION>OPINION OF FOLEY SHECHTER ABLOVATSKIY LLP REGARDING LEGALITY OF SECURITIES BEING REGISTERED
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex5-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Attorneys at Law</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">641 Lexington Avenue | 14<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dial: 212.335.0466</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fax: 917.688.4092</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">info@foleyshechter.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">www.foleyshechter.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">August 29, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LiveOne, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">269 S. Beverly Dr., Suite 1450</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Beverly Hills, CA 90212</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LiveOne, Inc.&rsquo;s Registration Statement on Form S-3 (File No. 333-______)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify; text-indent: -0.35in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify; text-indent: -0.35in">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is made to the Registration
Statement on Form S-3, as amended (File No. 333-______) (the &ldquo;<B>Registration Statement</B>&rdquo;) filed by LiveOne, Inc., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;),
with the U.S. Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) pursuant to Rule 415 under the Securities Act, with respect
to the resale by certain of the Company&rsquo;s securityholders (the &ldquo;<B>Selling Stockholders</B>&rdquo;), as set forth in the Registration
Statement, of (i) 3,000,000 shares (the &ldquo;<B>Shares</B>&rdquo;) of the Company&rsquo;s common stock, $0.001 par value per share (the
&ldquo;<B>common stock</B>&rdquo;), (ii) warrants to purchase up to an aggregate of 3,000,000 shares of common stock, exercisable at a
price of $0.01 per share (subject to adjustment as provided therein) (the &ldquo;<B>Warrants</B>&rdquo;), and (iii) up to 3,000,000 shares
of common stock issuable upon the exercise of the Warrants (the &ldquo;<B>Warrant Shares</B>&rdquo; and together with the Shares and the
Warrants, the &ldquo;<B>Securities</B>&rdquo;). The Shares and the Warrants were issued to the Selling Stockholders in a private placement
pursuant to the Letter Agreements entered into by the Company with each of the Selling Stockholders on July 15, 2025 (the &ldquo;<B>Letter
Agreements</B>&rdquo;). This opinion is being rendered in connection with the filing of the Registration Statement with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.05pt">In connection with this
opinion, we <FONT STYLE="background-color: white">have </FONT>examined the Registration Statement, the Letter Agreements, the Warrants
and such documents and considered such legal matters as we have deemed necessary and relevant as the basis for the opinion set forth below.
With respect to such examination, we have assumed the genuineness of all signatures, including electronic signatures, the legal capacity
and competency of all natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents
of all documents submitted to us as reproduced, certified or photostatic copies and the authenticity of the originals of those latter
documents. As to questions of fact material to this opinion, we have, to the extent deemed appropriate, relied upon certificates from,
and certain representations of certain officers and employees of, the Company. For purposes of the opinion set forth below, we have assumed
that before the Securities are issued the Company does not issue shares of common stock or reduce the total number of shares of common
stock the Company is authorized to issue under its Certificate of Incorporation, as amended (the &ldquo;<B>Certificate of Incorporation</B>&rdquo;),
such that the number of unissued shares of common stock authorized under the Certificate of Incorporation is less than the number of shares
of common stock underlying the Securities. With respect to the Securities, we express no opinion to the extent that future issuances of
securities of the Company, adjustments to outstanding securities of the Company or other matters cause the number of shares of common
stock underlying the Securities to be greater than the number of shares of common stock available for issuance by the Company. Further,
we have assumed that the exercise price of the Warrants will not be adjusted to an amount below the par value per share of the common
stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.05pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon the foregoing,
and subject to the additional qualifications set forth below, we are of the opinion that (i)(x) the Shares have been duly authorized by
all necessary corporate action of the Company, and, upon (i) the due execution by the Company and registration by its registrar of the
Shares, and (y) the issuance and delivery of the Shares, the Shares will be validly issued, fully paid and non-assessable, (ii) the Warrants
are valid and binding obligations of the Company enforceable against the Company in accordance with its terms, and (iii) the Warrant Shares
have been duly authorized by the Company and when paid for upon exercise of the Warrants in accordance with the terms of the Warrants,
will be validly issued, fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our opinion is expressed only
with respect to the General Corporation Law of the State of Delaware and the laws of the State of New York (the &ldquo;<B>Covered Law</B>&rdquo;).
The opinions set forth above are subject to the following exceptions, limitations and qualifications: (i) the effect of bankruptcy, insolvency,
reorganization, fraudulent conveyance, moratorium or other similar laws now or hereafter in effect relating to or affecting the rights
and remedies of creditors; (ii) the effect of general principles of equity, whether enforcement is considered in a proceeding in equity
or at law, and the discretion of the court before which any proceeding therefor may be brought; (iii) the unenforceability under certain
circumstances under law or court decisions of provisions providing for the indemnification of, or contribution to, a party with respect
to a liability where such indemnification or contribution is contrary to public policy; and (iv) we express no opinion concerning the
enforceability of any waiver of rights or defenses with respect to stay, extension or usury laws. We do not express any opinion with respect
to the law of any jurisdiction other than Covered Law or as to the effect of any such non-Covered Law on the opinions herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Without limiting the generality
of the foregoing, we express no opinion with respect to (i) the qualification of the shares under the securities or blue sky laws of any
state or any foreign jurisdiction or (ii) the compliance with any federal or state law, rule or regulation relating to securities, or
to the sale or issuance thereof. We are not rendering any opinion as to compliance with any federal or state antifraud law, rule, or regulation
relating to securities, or to the sale or issuance thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In rendering the foregoing
opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided
in the Covered Law. This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by
persons entitled to rely upon it pursuant to the applicable provisions of the Securities Act. It is understood that this opinion is to
be used only in connection with the offer, sale, and issuance of the Securities while the Registration Statement is in effect.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to the use
of this opinion as an exhibit to the Registration Statement, to the use of our name as your counsel and to all references made to us in
the Registration Statement and in the Prospectus forming a part thereof. In giving this consent, we do not hereby admit that we are in
the category of persons whose consent is required under Section 7 of the Act, or the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.05pt">Please note that we are
opining only as to the matters expressly set forth herein, and no opinion should be inferred as to any other matters. This opinion is
expressed as of the date hereof unless otherwise expressly stated and is based upon currently existing statutes, rules, regulations and
judicial decisions, and we disclaim any obligation to advise you of any change in any of these sources of law or subsequent legal or factual
developments which might affect any matters or opinions set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 300px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Foley Shechter Ablovatskiy LLP</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea025507201ex23-1_liveone.htm
<DESCRIPTION>CONSENT OF MACIAS GINI & O'CONNELL LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LiveOne, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Beverly Hills, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the incorporation by reference in
this Registration Statement on Form S-3 and the related Prospectus of LiveOne, Inc. of our report dated July 15, 2025, relating to the
consolidated financial statements of LiveOne, Inc. as of March 31, 2025, which report appears in the Annual Report on Form 10-K of LiveOne,
Inc. for the year ended March 31, 2025. Our report on the consolidated financial statements contains an explanatory paragraph regarding
the Company&rsquo;s ability to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also consent to the reference to our firm under the heading &ldquo;Experts&rdquo; in the Prospectus constituting a part of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Macias Gini &amp; O&rsquo;Connell, LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Los Angeles, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August 29, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ea025507201ex-fee_liveone.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FE.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.2b -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: c5ec21732beca23b0d62a3a4194d2b01 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">S-3</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0001491419</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_004"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_005">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-28</xbrli:startDate>
          <xbrli:endDate>2025-08-28</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-28</xbrli:startDate>
          <xbrli:endDate>2025-08-28</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_3">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>3</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-28</xbrli:startDate>
          <xbrli:endDate>2025-08-28</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001491419</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-28</xbrli:startDate>
          <xbrli:endDate>2025-08-28</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_007">S-3</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_008">LiveOne, Inc.</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_009">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_010">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_011">Common Stock, $0.001 par value per share</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_012">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_013">3,000,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">0.6065</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">1,819,500.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_017">278.57</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="fee_018">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="fee_019">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="fee_020">Common Stock issuable upon exercise of the Warrants</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="fee_021">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_022">3,000,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_023">0.6065</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_024">1,819,500.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_025">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_026">278.57</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_3" format="ixt:booleanfalse" id="fee_027">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_3" id="fee_028">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_3" id="fee_029">Warrants to purchase shares of Common Stock</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(3)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_3" format="ixt:booleantrue" id="fee_030">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_3" id="fee_031">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_3" id="fee_032">0.00</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_033">3,639,000.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_034">557.14</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_035">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_036">557.14</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="fee_037">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) of the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price with respect to the shares are calculated based on $0.6065 per share, the average of the high and low prices of the common stock, as reported on the Nasdaq Capital Market on August 22, 2025, a date within five business days prior to the filing of this Registration Statement.<br/></ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="fee_038">Represents shares issuable upon exercise of the warrants. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), the securities being registered hereunder include such indeterminate number of additional securities as may be issuable to prevent dilution resulting from stock splits, stock dividends or similar transactions.<br/><br/>Calculated pursuant to Rule 457(g) under the Securities Act, based on $0.6065 per share, the average of the high and low prices of the common stock, as reported on the Nasdaq Capital Market on August 22, 2025, a date within five business days prior to the filing of this Registration Statement.<br/></ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(3)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_3" id="fee_039">No separate registration fee required pursuant to Rule 457(g) under the Securities Act.<br/></ix:nonNumeric></td></tr>
  </table>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  [ 0 # 2(  A$! Q$!_\0
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MCU2=D6'3]"\/:;<ZMJU[*SLB+':V%I/.Q9T7"<L!D@ Z:BOYE/@U_P '6?\
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MO7]T_P#P>??\HV_@]_V<UX<_]1'Q17\+'[$W_*93X _]GYZ#_P"K@>O[I_\
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M/Q_\&IG_  6<B=)8O@AX%CDC8/')'\8/!J.CJ<JR.MX&5E(!#*001D&M<_\
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MOB!X3^(7CZ_UK3=#UR'QEY-GXP\6276A.NJ6L\\$GF6\\9ECCD,=L6\M54
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FL7FM7$3G[SCA(IQL^BBBOZ /]!PHHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  [ 0 # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBOYA_A
M#_P=D_\ !,;XU?%7X<_"#PAI?[0$?BGXG>-?#G@3P])J?PZM+73DUKQ1JMMH
M^F-?7":_,\%I]KNX1/,L4GE(6?:0IK^GCK0 44R1Q&CR-G;&C.<<G"@L<#N<
M#BOY:/&'_!W=_P $MO!'B[Q5X+UG2?VACJ_@_P 2ZYX6U1K7X<64UJVH:!J=
MUI5X]M*?$*-) US:2&)V1&*$%E5OEH _J:HK\8_^":W_  71_8Q_X*H?$SQW
M\*/V:[/XIVOB?X>^#8/'.N'Q[X1@\/V#Z-/J]MHRBSN(=4OS-="[NHBT+)'^
MZWL&RI%>%_MM?\')O[!/[ O[2/C_ /9<^/?ACX^67Q)^'@T6;4I-#^'UMJ&@
MZI9>(=&L]=TG4M#U*77+7^T-/NK&]AVW*0JHG6>W;$L$J* ?T(45\U?L@?M7
M?"7]M[]G3X9_M/\ P/U"_P!0^&OQ3TBXU703J]M#8ZW9-8ZE>:3J&FZUI\-S
M=C3]3L;^PN(;BT>9G0!'^[(I/M_C3Q?X?^'W@_Q7X\\6:A%I7A;P5X<UOQ9X
MCU2=D6'3]"\/:;<ZMJU[*SLB+':V%I/.Q9T7"<L!D@ Z:BOYE/@U_P '6?\
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MO7]T_P#P>??\HV_@]_V<UX<_]1'Q17\+'[$W_*93X _]GYZ#_P"K@>O[I_\
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M/Q_\&IG_  6<B=)8O@AX%CDC8/')'\8/!J.CJ<JR.MX&5E(!#*001D&M<_\
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MOB!X3^(7CZ_UK3=#UR'QEY-GXP\6276A.NJ6L\\$GF6\\9ECCD,=L6\M54
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FL7FM7$3G[SCA(IQL^BBBOZ /]!PHHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !" >4# 2(  A$! Q$!_\0
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MRS11B2;?,R>82(U51S]D?\.*_@S_ -%]^-7_ '[\(?\ REIN,4VG+5.WPO\
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MK?6;#]HCX?Z$D\222:=XWU)O ^KVCE0SV]QI_BB+3)'EB.5=[0W5L2I,4\B
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M6TF=*E)5]HF@+!Q^SW_!+'_DPS]G_P#[!/B[_P!6%XMKS'_@LO\ \F)^.?\
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MRKG5]'T@IJ5S!;W4,EA>6\=U;'^LE>@^@_E7\]/_  59^ 7BWX#_ !7\!_\
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M(^#?^'17["'_ $2?5/\ PO\ QQ_\O:/^'17["'_1)]4_\+_QQ_\ +VOO+_A
M;;_H:/'7_A6ZG_\ %T?\(#;?]#1XZ_\ "MU/_P"+I\\_YI?>PLNR^Y'A/[.W
M[%GP,_97\2>,?$'P6T?6/#<7CG1= TC7M%N]=U#7--=_#E[K%Y8ZC;2:O+=Z
MA;7;C6KFWN42]-I)'' ZVZ3*\DGU?(@D1XRS*'1D+(Q5UW C<C#E7&258<A@
M".17#GP#;'_F:/'74G_D;=3[_P# Z3_A ;7_ *&?QUW_ .9MU3O_ ,#[=O\
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MX2?QT><\^+-3_+[_ $]J2;6S:]'8&K]$_7_AF?/WP3_8._90_9^O;36/AO\
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M2=3UW5=>73'U.X:\O8+"YUBZN[FVLYKR2>\^R)*($N;FYF1%>:0G>/@&U/\
MS,_CH<8X\6ZF/Q^_U]Z7_A ;;G_BI_'/.?\ F;-3XSZ?/V[47TM=V[=+_?\
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M6\L\"Q27$,%K'.9%M;<1E?0UGX.M[/S-NO\ BZX\S9G[7XDU"XV;-^/+WO\
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MZM)+OP]J&@W#PSWW@$Z;(T5KXCU;Q#:(JII[R!-$C:V\27$MM<6>D+>?U_\
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J1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Aug. 28, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001491419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">LiveOne, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Aug. 28, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.6065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 1,819,500.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 278.57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) of the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price with respect to the shares are calculated based on $0.6065 per share, the average of the high and low prices of the common stock, as reported on the Nasdaq Capital Market on August 22, 2025, a date within five business days prior to the filing of this Registration Statement.<br/><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock issuable upon exercise of the Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.6065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 1,819,500.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 278.57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Represents shares issuable upon exercise of the warrants. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), the securities being registered hereunder include such indeterminate number of additional securities as may be issuable to prevent dilution resulting from stock splits, stock dividends or similar transactions.<br/><br/>Calculated pursuant to Rule 457(g) under the Securities Act, based on $0.6065 per share, the average of the high and low prices of the common stock, as reported on the Nasdaq Capital Market on August 22, 2025, a date within five business days prior to the filing of this Registration Statement.<br/><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=3', window );">Offering: 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants to purchase shares of Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">No separate registration fee required pursuant to Rule 457(g) under the Securities Act.<br/><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Aug. 28, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 3,639,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">557.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 557.14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea025507201ex-fee_liveone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea025507201ex-fee_liveone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea025507201ex-fee_liveone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ea025507201ex-fee_liveone.htm">ea025507201ex-fee_liveone.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea025507201ex-fee_liveone.htm": {
   "dts": {
    "inline": {
     "local": [
      "ea025507201ex-fee_liveone.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/ffd/2025": 5,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 37,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025507201ex-fee_liveone.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025507201ex-fee_liveone.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025507201ex-fee_liveone.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025507201ex-fee_liveone.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025507201ex-fee_liveone.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025507201ex-fee_liveone.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001213900-25-082659-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-082659-xbrl.zip
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F+69E95]L:79E;VYE+FAT;5!+!08      0 ! $L   !M#      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>ea025507201ex-fee_liveone_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-28</startDate>
            <endDate>2025-08-28</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-28</startDate>
            <endDate>2025-08-28</endDate>
        </period>
    </context>
    <context id="c_offering_3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-28</startDate>
            <endDate>2025-08-28</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001491419</identifier>
        </entity>
        <period>
            <startDate>2025-08-28</startDate>
            <endDate>2025-08-28</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">S-3</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0001491419</dei:EntityCentralIndexKey>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_004" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_005">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_006">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_007">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_008">LiveOne, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_009">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_010">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_011">Common Stock, $0.001 par value per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_1" id="fee_012">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_013"
      unitRef="shares">3000000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_014"
      unitRef="USD">0.6065</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="USD">1819500.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_017"
      unitRef="USD">278.57</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="fee_018">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="fee_019">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="fee_020">Common Stock issuable upon exercise of the Warrants</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="fee_021">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="fee_022"
      unitRef="shares">3000000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_023"
      unitRef="USD">0.6065</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_024"
      unitRef="USD">1819500.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_025"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_026"
      unitRef="USD">278.57</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_3" id="fee_027">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_3" id="fee_028">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_3" id="fee_029">Warrants to purchase shares of Common Stock</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_3" id="fee_030">true</ffd:FeesOthrRuleFlg>
    <ffd:FeeRate
      contextRef="c_offering_3"
      decimals="INF"
      id="fee_031"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_3"
      decimals="INF"
      id="fee_032"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_033"
      unitRef="USD">3639000.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_034"
      unitRef="USD">557.14</ffd:TtlFeeAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_035"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_036"
      unitRef="USD">557.14</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="fee_037">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) of the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price with respect to the shares are calculated based on $0.6065 per share, the average of the high and low prices of the common stock, as reported on the Nasdaq Capital Market on August 22, 2025, a date within five business days prior to the filing of this Registration Statement.&lt;br/&gt;</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="fee_038">Represents shares issuable upon exercise of the warrants. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), the securities being registered hereunder include such indeterminate number of additional securities as may be issuable to prevent dilution resulting from stock splits, stock dividends or similar transactions.&lt;br/&gt;&lt;br/&gt;Calculated pursuant to Rule 457(g) under the Securities Act, based on $0.6065 per share, the average of the high and low prices of the common stock, as reported on the Nasdaq Capital Market on August 22, 2025, a date within five business days prior to the filing of this Registration Statement.&lt;br/&gt;</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_3" id="fee_039">No separate registration fee required pursuant to Rule 457(g) under the Securities Act.&lt;br/&gt;</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
